



A Unified Total Synthesis of the Actinoallolides, a
Family of Potent Antitrypanosomal Macrolides
Matthew J. Anketell, Theodore M. Sharrock and Ian Paterson*
Abstract: Trypanosoma protozoan parasites are the causative agents of Chagas disease
and sleeping sickness, two neglected tropical diseases where there is an urgent need for
improved treatments and the evaluation of promising drug leads like the actinoallolides.
Enabled by the highly stereocontrolled aldol reactions of three chiral ketone building
blocks, an efficient first total synthesis of the potent anti-trypanosomal macrolide (+)-
actinoallolide A has been achieved in 17 steps and 8% overall yield. Our convergent
route features an adventurous ring-closing metathesis to form the requisite trisubstituted
(8E )-alkene in the 12-membered macrolactone, followed by the controlled installation of
the labile transannular hemiacetal. Late-stage diversification then provides ready access
to the congeneric (+)-actinoallolides B-E.
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The numbering system used for the actinoallolides follows that proposed by Omura and co-
workers as shown below.1 Methyl groups are denoted with reference to the skeletal carbon atom


















1.1 General experimental procedures
Reagents were purified using standard laboratory procedures2 and stored under an atmos-
phere of argon unless otherwise specified. Dichloromethane was distilled from calcium hydride.
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from potassium and sodium
wire respectively with benzophenone as a radical indicator. Triethylamine (Et3N) and diiso-
propylethylamine (DIPEA) were distilled from calcium hydride. Dicyclohexylboron chloride
(Cy2BCl) was distilled neat. All other chemicals were used as received from the supplier. All
aqueous solutions were saturated unless otherwise stated.
Air or water sensitive reactions were carried out under positive pressure of argon in oven-dried
glassware using standard air-free techniques. Purification by flash column chromatography was
carried out using Merck Kieselgel 60 (230-400 mesh) silica gel and positive pressure of solvent.
1.2 Analytical procedures
TLC analysis was carried out using Merck Kieselgel 60 F254 plates and distilled solvents. The
plates were visualised using UV (254 nm) light and stained using either a potassium perman-
ganate or phosphomolybdic acid/cerium sulfate dip followed by heating.
NMR spectra were recorded using the following instruments: 400 MHz QNP Cryoprobe, 400
MHz AVIII HD BBO Smart Probe, 500 MHz DCH Cryoprobe, 500 MHz AVIII HD BBO Smart
Probe, 500 MHz TCI Cryoprobe, 600 MHz Avance 600 BBI, 700 MHz TXO Cryoprobe. 1H
NMR spectra were recorded at 298 K in CDCl3 using an internal deuterium solvent lock. These
data are presented in the following format: chemical shift (δ/ppm, relative to trace undeuterated
solvent (δH=7.26)), integration, multiplicity and coupling constants, assignment. Assignments
have been made using the data shown as well as 2-D COSY, HSQC and HMBC spectra and
comparison to assigned spectra of similar compounds. 13C NMR spectra were recorded at 298 K
in CDCl3 using an internal deuterium solvent lock. Peaks are listed by chemical shift (δ/ppm)
relative to solvent (δC=77.0).
Fourier transform infrared (IR) spectroscopy was carried out using the thin-film technique
on a Perkin-Elmer Spectrum One spectrometer. Maximal absorption wavelengths (νmax) are
reported in wavenumbers (cm-1) and especially broad peaks are noted.
Optical rotation was measured at the sodium D line (589 nm) on a Perkin-Elmer 241 polarimeter
using chloroform as the solvent and is reported as follows: [α]20D , concentration (in g/100 mL).
High resolution mass spectrometry (HRMS) was carried out at the EPSRC UK National Mass
Spectrometry Facility at Swansea University or the departmental mass spectrometry service
(University Chemical Laboratories, Cambridge) using electrospray (ES) or nanospray (NS) ion-
isation techniques. The calculated and observed masses of the [M+H]+, [M+Na]+, [M+K]+,
[M+NH4]
+ or [M-H]- ions are reported.
3






To a stirred solution of ketone 8 (5.00 g, 21.2 mmol) in CH2Cl2 (100 mL) at −78 °C was added
a solution of Ti(OiPr)Cl3 (23.3 mmol) in CH2Cl2 (50 mL). DIPEA (4.05 mL, 23.3 mmol) was
added dropwise followed by a solution of methacrolein (2.63 mL, 31.8 mmol) in CH2Cl2 (35
mL) over 1 h. Reaction progress was monitored by TLC and upon completion (30 min) was
slowly added LiBH4 at −78 °C (10.6 mL, 4 M in THF, 42.3 mmol). The reaction mixture was
stirred for a further hour before quenching with AcOH (10 mL) and potassium sodium tartrate
solution (100 mL). The phases were separated and the aqueous phase extracted with CH2Cl2
(3 × 100 mL). The combined organic extracts were stirred for 18 h with additional potassium
sodium tartrate solution, dried with MgSO4, concentrated in vacuo and purified by flash column
chromatography (P.E. 40-60:EtOAc, 10:1) to give diol 9 as a colourless oil (5.65 g, 19.1 mmol,
90%).
Rf: 0.16 (PE:EtOAc, 6:1). [α]
20
D : −3.7 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.23
(2H, d, J = 8.6 Hz, HPMB Ar-H ), 6.87 (2H, d, J = 8.6 Hz, HPMB Ar-H ), 5.02 (1H, m, H15A), 4.92
(1H, m, H15B), 4.42 (2H, s, HPMB ArCH2O), 4.20 (1H, m, H17), 3.80 (3H, s, MeOPMB), 3.80 (1H,
m, H19), 3.43 (2H, m, H21), 2.90 (1H, d, J = 3.3 Hz, HO17), 2.44 (1H, d, J = 3.0 Hz, HO19),
1.98 (1H, m, H20), 1.86 (1H, m, H18), 1.66 (3H, s, Me16), 1.06 (3H, d, J = 6.9 Hz, Me20), 0.86
(3H, d, J = 7.0 Hz, Me18).
13C NMR (125 MHz, CDCl3): δ 159.2, 145.9, 130.3, 129.2, 113.8,
110.2, 78.7, 78.2, 73.9, 73.0, 55.3, 36.9, 36.8, 29.7, 19.6, 13.2, 5.9. IR (thin film, νmax/cm
-1):









To a stirred solution of diol 9 (700 mg, 2.27 mmol) in CH2Cl2 (20 mL) at 0 °C was added Et3N
(2.30 mL, 22.7 mmol), propionic anhydride (2.90 mL, 22.7 mmol) and DMAP (one crystal).
The mixture was warmed to rt and stirred for 18 h before quenching with NaHCO3 solution (10
mL). The phases were separated and the aqueous phase extracted with CH2Cl2 (3 × 10 mL).
The combined organic extracts were dried with MgSO4, concentrated in vacuo and purified by
flash column chromatography (P.E. 40-60:EtOAc, 20:1) to give diester 10 as a colourless oil
(952 mg, 2.26 mmol, 99%).
Rf: 0.53 (PE:EtOAc, 6:1). [α]
20
D : −13.7 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.24
(2H, d, J = 8.5 Hz, HPMB Ar-H ), 6.86 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 5.14 (1H, d, J = 5.1
4
Hz, H17), 5.05 (1H, dd, J = 6.6, 4.4 Hz, H19), 4.92 (1H, m, H15A), 4.83 (1H, m, H15B), 4.36
(2H, s, HPMB ArCH2O), 3.80 (3H, s, MeOPMB), 3.25 (2H, ABQ, H21), 2.31 (4H, m, HPropionate),
2.10 (1H, m, H20), 2.10 (1H, m, H18), 1.68 (3H, s, Me16), 1.14 (3H, t, J = 7.6 Hz, MePropionate),
1.10 (3H, t, J = 7.6 Hz, MePropionate), 0.91 (3H, d, J = 7.2 Hz, Me20), 0.89 (3H, d, J = 6.9
Hz, Me18).
13C NMR (125 MHz, CDCl3): δ 173.8, 173.6, 159.0, 141.3, 130.6, 129.2, 113.6,
113.0, 76.8, 74.4, 72.7, 72.6, 55.3, 36.2, 35.1, 27.7, 27.7, 18.9, 11.6, 9.9, 9.4, 9.1. IR (thin film,
νmax/cm
-1): 2975, 2942, 1737, 1613, 1514, 1462, 1248, 1181, 1098. HRMS (ES+): Calculated
for C24H37O6 [M+H]








To a stirred solution of diester 10 (50 mg, 0.119 mmol) in THF (15 mL) at −78 °C was added
premixed and filtered Et3N/TMSCl (0.30 mL, 1:1 v/v) and LDA (0.80 mL, 0.5 M in THF,
0.400 mmol). The mixture was stirred for 1.5 h then warmed to rt and stirred for a further 2
h before diluting with THF (15 mL) and heating to reflux for 4 h. The mixture was cooled to
rt, diluted with ether (20 mL) and washed with 1 M HCl. The organic phase was dried with
MgSO4, concentrated in vacuo and the crude product submitted to the next reaction without
purification.
Rf: 0.42 (PE:EtOAc, 1:1). [α]
20
D : −1.0 (c 1.0, CHCl3).1H NMR (400 MHz, CDCl3): δ 7.26
(2H, d, J = 8.5 Hz, HPMB Ar-H ), 6.87 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 4.97 (1H, d, J = 10.0
Hz, H17), 4.84 (1H, dd, J = 9.5, 2.2 Hz, H19), 4.50 (1H, d, J = 11.4 Hz, HPMB ArCH2O), 4.38
(1H, d, J = 11.4 Hz, HPMB ArCH2O), 3.80 (3H, s, MeOPMB), 3.24 (2H, m, H21), 2.64 (1H, m,
H14), 2.64 (1H, m, H18), 2.33 (2H, q, J = 7.6 Hz, HPropionate), 2.25 (1H, dd, J = 13.2, 10.0 Hz,
H15A), 2.09 (1H, dd, J = 13.2, 6.3 Hz, H15B), 2.06 (1H, m, H20), 1.64 (3H, s, Me16), 1.14 (3H,
t, J = 7.6 Hz, HPropionate), 1.13 (3H, d, J = 6.9 Hz, Me14), 0.88 (3H, d, J = 6.6 Hz, Me20),










To a stirred solution of carboxylic acid 11 (50 mg, 0.119 mmol) in acetone (5 mL) was added
K2CO3 (82 mg, 0.594 mmol) and MeI (0.074 mL, 1.19 mmol). The mixture was stirred for 24 h
followed by addition of MeOH (2 mL) and stirring for an additional 2 h. The solvent was removed
in vacuo and the residue dissolved in ether (5 mL) and H2O (5 mL). The phases were separated
and the aqueous phase extracted with ether (3 × 50 mL). The combined organic extracts were
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dried with MgSO4, concentrated in vacuo and purified by flash column chromatography (P.E.
40-60:EtOAc, 20:1) to give methyl ester S1 as a colourless oil (45 mg, 104 mmol, 87%).
Rf: 0.46 (PE:EtOAc, 6:1). [α]
20
D : −5.5 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.24
(2H, d, J = 8.7 Hz, HPMB Ar-H ), 6.86 (2H, d, J = 8.7 Hz, HPMB Ar-H ), 4.95 (1H, m, H17), 4.95
(1H, m, H19), 4.39 (1H, d, J = 11.5 Hz, HPMB ArCH2O), 4.35 (1H, d, J = 11.5 Hz, HPMB ArCH2O),
3.80 (3H, s, MeOPMB), 3.63 (3H, s, MeO), 3.24 (1H, dd, J = 9.1, 7.0 Hz, H21A), 3.14 (1H, dd,
J = 9.1, 6.8 Hz, H21B), 2.63 (1H, m, H14), 2.63 (1H, m, H18), 2.36 (1H, dd, J = 13.7, 7.4 Hz,
H15A), 2.31 (2H, q, J = 7.6 Hz, HPropionate), 2.02 (1H, dd, J = 13.7, 7.4 Hz, H15B), 2.00 (1H,
m, H20), 1.62 (3H, d, J = 1.3 Hz, Me16), 1.13 (3H, t, J = 7.6 Hz, HPropionate), 1.09 (3H, d, J
= 6.9 Hz, Me14), 0.87 (3H, d, J = 6.8 Hz, Me20), 0.87 (3H, d, J = 6.8 Hz, Me18).
13C NMR
(125 MHz, CDCl3): δ 176.9, 174.1, 159.1, 132.5, 130.7, 129.3, 129.1, 113.7, 76.9, 73.1, 72.8, 55.3,
51.6, 43.8, 37.8, 35.5, 34.8, 27.8, 17.6, 16.7, 16.0, 10.6, 9.5. IR (thin film, νmax/cm
-1): 2973,
1737, 1613, 1514, 1461, 1360, 1248, 1186, 1086, 821. HRMS (ES+): Calculated for C25H39O6







To a stirred solution of diester S1 (893 mg, 2.05 mmol) in toluene (40 mL) at −78 °C was
added DIBAL-H (4.32 mL, 1 M in toluene, 4.32 mmol). The reaction mixture was stirred at
−78 °C for 1 h before quenching with MeOH (1 mL) and potassium sodium tartrate solution
(20 mL). The phases were separated and the aqueous phase extracted with ether (3 × 20 mL).
The combined organic extracts were dried with MgSO4, concentrated in vacuo and purified by
flash column chromatography (P.E. 40-60:EtOAc, 20:1) to give aldehyde 12 as a colourless oil
(634 mg, 1.82 mmol, 89%).
Rf: 0.14 (PE:EtOAc, 6:1). [α]
20
D : −11.9 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ
9.59 (1H, d, J = 2.1 Hz, H13), 7.24 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 6.87 (2H, d, J = 8.5
Hz, HPMB Ar-H ), 4.93 (1H, d, J = 9.9 Hz, H17), 4.45 (1H, d, J = 11.6 Hz, HPMB ArCH2O), 4.42
(1H, d, J = 11.6 Hz, HPMB ArCH2O), 3.81 (3H, s, MeOPMB), 3.51 (1H, m, H19), 3.48 (2H, m,
H21), 2.72 (1H, d, J = 2.8 Hz, HO19), 2.48 (1H, m, H14), 2.48 (1H, m, H18), 2.39 (1H, dd, J
= 13.7, 6.6 Hz, H15A), 1.96 (1H, dd, J = 13.7, 7.9 Hz, H15B), 1.80 (1H, m, H20), 1.63 (3H, s,
Me16), 1.02 (3H, d, J = 6.7 Hz, Me14), 1.02 (3H, d, J = 6.7 Hz, Me18), 0.90 (3H, d, J = 7.0
Hz, Me20).
13C NMR (125 MHz, CDCl3): δ 204.6, 158.9, 130.7, 130.4, 129.8, 128.8, 113.5,
77.7, 75.2, 72.8, 54.9, 44.0, 40.6, 36.3, 35.2, 17.6, 15.8, 12.7, 9.4. IR (thin film, νmax/cm
-1):
3527 (br), 2931, 2353, 1724, 1513, 1247, 1089, 822. HRMS (ES+): Calculated for C21H33O4











To a stirred solution of Cy2BCl (3.90 mL, 17.8 mmol) in ether (18 mL) at 0 °C was added
Et3N (2.63 mL, 18.9 mmol) then a solution in ether (15 mL) of ketone 13 (3.54 g, 17.2 mmol).
The mixture was stirred at 0 °C for 1.5 h before cooling to −78 °C. A solution of aldehyde 12
(1.73 mg, 4.91 mmol) in ether (15 mL) was added and the mixture stirred at −78 °C for 4 h
then at -20 °C for 18 h and finally at 0 °C for 1.5 h. The reaction mixture was quenched with
MeOH (12 mL), pH 7 buffer (12 mL) and H2O2 (30%, 11 mL) and stirred at rt for 1 h. The
phases were separated and the aqueous phase extracted with ether (3 × 50 mL). The combined
organic extracts were dried with MgSO4, concentrated in vacuo and purified by flash column
chromatography (P.E. 40-60:EtOAc, 20:1) to give aldol adduct 14 as a colourless oil (2.43 g,
4.38 mmol, 89%).
Rf: 0.07 (PE:EtOAc, 6:1). [α]
20
D : +13.0 (c 1.0 CHCl3).
1H NMR (400 MHz, CDCl3): δ 8.08
(2H, d, J = 7.9 Hz, HBz), 7.59 (1H, t, J = 7.4 Hz, HBz), 7.46 (2H, t, J = 7.7 Hz, HBz), 7.23
(2H, d, J = 8.6 Hz, HPMB Ar-H ), 6.87 (2H, d, J = 8.6 Hz, HPMB Ar-H ), 5.46 (1H, q, J = 7.1
Hz, H10), 4.87 (1H, d, J = 10.0 Hz, H17), 4.43 (2H, ABQ, J = 11.6 Hz, HPMB ArCH2O), 3.80
(3H, s, MeOPMB), 3.56 (1H, m, H13), 3.50 (1H, m, H19), 3.49 (2H, m, H21), 3.07 (1H, q, J =
7.1 Hz, H12), 2.68 (1H, d, J = 2.9 Hz, HO19), 2.47 (1H, m, H18), 2.41 (1H, d, J = 7.0 Hz,
HO13), 2.25 (1H, d, J = 12.6 Hz, H15A), 1.85 (1H, m, H20), 1.71 (1H, m, H14), 1.70 (1H, dd, J
= 12.6, 11.3 Hz, H15B), 1.59 (3H, s, Me16), 1.57 (3H, d, J = 7.1 Hz, Me10), 1.28 (3H, d, J =
6.6 Hz, Me12), 1.02 (3H, d, J = 6.5 Hz, Me18), 0.91 (3H, d, J = 7.0 Hz, Me20), 0.82 (3H, d,
J = 6.5 Hz, Me14).
13C NMR (125 MHz, CDCl3): δ 212.2, 165.9, 159.2, 133.4, 132.7, 130.2,
129.8, 129.8, 129.4, 129.2, 128.5, 113.8, 78.3, 78.0, 75.6, 74.6, 73.1, 55.3, 44.8, 40.4, 36.6, 35.6,
33.3, 18.0, 16.3, 16.1, 16.0, 14.7, 9.9. IR (thin film, νmax/cm
-1): 2934, 1718, 1250, 1114, 713.
HRMS (ES+): Calculated for C33H47O7 [M+H]
+: 555.3322, found 555.3318.










To a stirred solution of diol 14 (2.43 g, 4.37 mmol) in CH2Cl2 (30 mL) at −78 °C was added
2,6-lutidine (2.00 mL, 17.3 mmol) then TESOTf (3.00 mL, 13.3 mmol). After 2 h, the reaction
mixture was quenched by addition of MeOH (6 mL) then NaHCO3 solution (20 mL). The phases
were separated and the aqueous phase extracted with CH2Cl2 (3 × 20 mL). The combined
organic extracts were dried with MgSO4, concentrated in vacuo and purified by flash column
chromatography (P.E. 40-60:EtOAc, 20:1) to give bis TES ether S2 as a colourless oil (3.40 mg,
4.34 mmol, 99%).
Rf: 0.71 (PE:EtOAc, 6:1). [α]
20
D : +3.0 (c 1.0 CHCl3).
1H NMR (400 MHz, CDCl3): δ 8.08
(2H, d, J = 8.0 Hz, HBz), 7.57 (1H, t, J = 7.4 Hz, HBz), 7.45 (2H, t, J = 7.7 Hz, HBz), 7.25
(2H, d, J = 8.6 Hz, HPMB Ar-H ), 6.87 (2H, d, J = 8.6 Hz, HPMB Ar-H ), 5.44 (1H, q, J = 7.0
Hz, H10), 4.89 (1H, d, J = 9.7 Hz, H17), 4.43 (1H, d, J = 11.6 Hz, HPMB ArCH2O), 4.38 (1H,
d, J = 11.6 Hz, HPMB ArCH2O), 3.94 (1H, d, J = 9.0 Hz, H13), 3.80 (3H, s, MeOPMB), 3.56
(1H, dd, J = 8.4, 2.2, H19), 3.35 (1H, dd, J = 8.8, 7.8 Hz, H21A), 3.19 (1H, dd, J = 8.8, 6.7
Hz, H21B), 3.11 (1H, m, H12), 2.46 (1H, m, H18), 2.08 (1H, m, H15A), 1.93 (1H, m, H20), 1.76
(1H, m, H14), 1.75 (1H, m, H15B), 1.55 (3H, s, Me16), 1.51 (3H, d, J = 7.0 Hz, Me10), 1.11
7
(3H, d, J = 7.0 Hz, Me12), 0.94 (18H, m, SiCH2CH3), 0.92 (3H, m, Me18), 0.84 (3H, d, J = 6.2
Hz, Me14), 0.82 (3H, d, J = 6.8 Hz, Me20), 0.58 (12H, m, SiCH2CH3).
13C NMR (125 MHz,
CDCl3): δ 209.2, 165.7, 159.1, 133.2, 132.0, 130.8, 130.5, 129.8, 129.8, 129.3, 128.4, 113.7, 78.2,
77.2, 75.0, 73.5, 72.5, 55.2, 46.1, 41.0, 37.1, 37.0, 34.2, 18.3, 16.0, 16.0, 15.5, 14.3, 10.8, 7.1, 7.0,
5.5, 5.3. IR (thin film, νmax/cm
-1): 2955, 1722, 1514, 1457, 1249. HRMS (ES+): Calculated
for C45H78O7Si2N [M+NH4]











To a stirred solution of ketone S2 (843 mg, 1.07 mmol) in THF (10 mL) at −78 °C was added
LiBH4 (1.63 mL, 4 M in hexanes, 6.5 mmol). The reaction mixture was warmed to rt and
stirred for 24 h before quenching with NH4Cl (10 mL). The phases were separated and the
aqueous phase extracted with ether (3 × 10 mL). The combined organic extracts were dried
with MgSO4, concentrated in vacuo and the crude product submitted to the next reaction
without purification.
Rf: 0.32 (PE:EtOAc, 6:1).
1H NMR (400 MHz, CDCl3): δ 7.25 (2H, d, J = 8.4 Hz,
HPMB Ar-H ), 6.87 (2H, d, J = 8.4 Hz, HPMB Ar-H ), 4.91 (1H, d, J = 9.8 Hz, H17), 4.44 (1H, d,
J = 11.5 Hz, HPMB ArCH2O), 4.38 (1H, d, J = 11.5 Hz, HPMB ArCH2O), 3.81 (3H, s, MeOPMB),
3.77 (1H, m, H11), 3.63 (1H, m, H10), 3.57 (1H, dd, J = 8.4, 1.9, H19), 3.51 (1H, t, J = 4.9 Hz,
H13), 3.48 (1H, s, HO11), 3.35 (1H, dd, J = 8.7, 7.9 Hz, H21A), 3.20 (1H, dd, J = 8.7, 6.8 Hz,
H21B), 2.83 (1H, d, J = 8.4 Hz, HO10), 2.48 (1H, m, H18), 2.19 (1H, d, J = 13.0 Hz, H15A),
1.93 (1H, m, H20), 1.81 (1H, m, H14), 1.76 (1H, m, H12), 1.61 (1H, m, H15B), 1.56 (3H, s, Me16),
1.17 (3H, d, J = 6.3 Hz, Me10), 0.99 (9H, t, J = 7.9 Hz, SiCH2CH3), 0.95 (9H, t, J = 7.9 Hz,
SiCH2CH3), 0.93 (3H, m, Me18), 0.82 (3H, m, Me20), 0.82 (3H, m, Me14), 0.60 (6H, q, J = 7.9











To a stirred solution of crude diol S3 (730 mg, 1.07 mmol) in CH2Cl2 (15 mL) was added
NaIO4 on SiO2 (8.80 g, 14% w/w, 5.87 mmol). The reaction mixture was stirred for 1 h before
filtering through celite. The residue was concentrated in vacuo and purified by flash column
chromatography (P.E. 40-60:EtOAc, 20:1) to give aldehyde 15 as a colourless oil (580 mg, 0.913
mmol, 85% over 2 steps).
Rf: 0.74 (PE:EtOAc, 6:1). [α]
20
D : −12.0 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ
9.78 (1H, d, J = 2.7 Hz, H11), 7.24 (2H, d, J = 8.6 Hz, HPMB Ar-H ), 6.87 (2H, d, J = 8.6 Hz,
HPMB Ar-H ), 4.90 (1H, d, J = 9.8 Hz, H17), 4.43 (1H, d, J = 11.5 Hz, HPMB ArCH2O), 4.37 (1H,
8
d, J = 11.5 Hz, HPMB ArCH2O), 3.81 (3H, s, MeOPMB), 3.72 (1H, t, J = 4.4 Hz, H13), 3.57
(1H, dd, J = 8.4, 2.1, H19), 3.34 (1H, dd, J = 8.8, 7.8 Hz, H21A), 3.19 (1H, dd, J = 8.8, 6.6
Hz, H21B), 2.52 (1H, m, H12), 2.48 (1H, m, H18), 2.14 (1H, dd, J = 12.9, 4.3 Hz, H15A), 1.92
(1H, m, H20), 1.83 (1H, m, H14), 1.70 (1H, dd, J = 12.9, 10.0 Hz, H15B), 1.55 (3H, s, Me16),
1.09 (3H, d, J = 7.0 Hz, Me12), 0.96 (9H, t, J = 7.9 Hz, SiCH2CH3), 0.95 (9H, t, J = 7.9
Hz, SiCH2CH3), 0.93 (3H, m, Me18), 0.82 (3H, d, J = 6.8 Hz, Me20), 0.79 (3H, d, J = 6.8 Hz,
Me14), 0.60 (12H, m, SiCH2CH3).
13C NMR (125 MHz, CDCl3): δ 205.4, 159.1, 131.7, 130.9,
130.7, 129.3, 113.7, 78.7, 76.9, 73.5, 72.6, 55.3, 49.2, 43.2, 37.1, 36.2, 29.7, 18.3, 16.0, 15.1, 12.3,
10.7, 7.2, 7.0, 5.6, 5.2. IR (thin film, νmax/cm
-1): 2956, 2876, 1724, 1613, 1513, 1459, 1247,
1082, 1039, 1008, 820, 738. HRMS (ES+): Calculated for C36H67O5Si2 [M+H]
+: 635.4522,
found 635.4519.










To a stirred solution of aldehyde 15 (5 mg, 7.89 µM) in CH2Cl2 (0.3 mL) over crushed CaH2
at −78 °C was added allyltributyltin (5 µL, 15.8 µM) then BF3·Et2O (1.5 µL, 11.8 µM). The
reaction mixture was stirred for 2 h, then quenched by addition of MeOH (50 µL) then NH4Cl
solution (1 mL). The phases were separated and the aqueous phase extracted with CH2Cl2
(3 × 2 mL). The combined organic extracts were dried with MgSO4, concentrated in vacuo
and purified by flash column chromatography (P.E. 40-60:EtOAc, 10:1) to give alcohol 7 as a
colourless oil (4.7 mg, 6.94 µM, 88%, dr = 15:1).
Rf: 0.52 (PE:EtOAc, 6:1). [α]
20
D : +14.0 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 7.25
(2H, d, J = 8.6 Hz, HPMB Ar-H ), 6.87 (2H, d, J = 8.6 Hz, HPMB Ar-H ), 5.80 (1H, dddd, J =
17.2, 10.2, 7.4, 6.9 Hz, H9), 5.11 (1H, dd, J = 17.2, 1.7 Hz, H8A), 5.06 (1H, d, J = 10.2 Hz,
H8B), 4.90 (1H, d, J = 9.5 Hz, H17), 4.43 (1H, d, J = 11.5 Hz, HPMB ArCH2O), 4.39 (1H, d, J
= 11.5 Hz, HPMB ArCH2O), 4.11 (1H, t, J = 7.1 Hz, H11), 3.81 (3H, s, MeOPMB), 3.57 (1H, m,
H19), 3.55 (1H, s, HO11), 3.48 (1H, dd, J = 7.4, 2.3 Hz, H13), 3.36 (1H, dd, J = 8.9, 7.5 Hz,
H21A), 3.20 (1H, dd, J = 8.9, 6.7 Hz, H21B), 2.48 (1H, m, H18), 2.31 (1H, m, H10A), 2.27 (1H,
m, H15A), 2.09 (1H, m, H10B), 1.93 (1H, m, H20), 1.88 (1H, m, H14), 1.73 (1H, m, H12), 1.56
(3H, s, Me16), 1.52 (1H, m, H15B), 1.00 (3H, d, J = 7.3 Hz, Me12), 0.98 (9H, t, J = 7.9 Hz,
SiCH2CH3), 0.95 (9H, t, J = 7.9 Hz, SiCH2CH3), 0.94 (3H, m, Me18), 0.83 (3H, d, J = 6.9
Hz, Me20), 0.75 (3H, d, J = 6.8 Hz, Me14), 0.67 (6H, q, J = 7.9 Hz, SiCH2CH3), 0.60 (6H, q,
J = 7.9 Hz, SiCH2CH3).
13C NMR (125 MHz, CDCl3): δ 159.1, 135.5, 132.0, 131.0, 130.7,
129.3, 116.9, 113.7, 83.8, 76.9, 73.6, 72.6, 70.6, 55.3, 44.2, 39.4, 37.0, 37.0, 36.6, 35.5, 18.1, 15.9,
15.2, 11.7, 11.0, 7.2, 7.0, 5.6, 5.4. IR (thin film, νmax/cm
-1): 2954, 1514, 1462, 1247, 1090,









A solution of L-(+)-lactic acid (85% in H2O, 14.6 g, 138 mmol) and (MeO)3CH (30.2 mL,
276 mmol) in cyclohexane (150 mL) was heated at 80 °C using Dean-Stark apparatus for 1 h
with continual removal of a MeOH/cyclohexane mixture. The reaction was cooled to rt and
concentrated in vacuo. Hexane (100 mL) as added and the solution cooled to 0 °C, followed by
addition of p-TsOH·H2O (0.600 g, 3.15 mmol). A solution of tBuCHO (10.0 mL, 92.1 mmol)
in hexane (20 mL) was then added dropwise at 0 . The reaction mixture was stirred at rt
for 2 h, before being quenched with NaHCO3 (200 mL). The layers were separated and the
aqueous phase was extracted with EtOAc (3 × 100 mL). The combined organic phases were
dried (MgSO4) and concentrated in vacuo to give crude dioxolanone 16. This was purified
by distillation under reduced pressure (62-64 , 15 mmHg) to give pure dioxolanone 16 as a
colourless oil (10.6 g, 101 mmol, 73%, >20:1 dr).
Rf: 0.48 (PE:EtOAc, 4:1).
1H NMR (400 MHz, CDCl3): δ 5.15 (1H, d, J = 1.2 Hz, HCHtBu),
4.36 (1H, qd, J = 6.7, 1.2 Hz, H6), 1.48 (3H, d, J = 6.7 Hz, Me6), 0.98 (9H, s,
tBu).







To a solution of LDA (12.4 mmol) in THF (50 mL) at −78  was added dropwise dioxolanone
16 (1.77 g, 11.2 mmol) in THF (10 mL) and the solution was stirred for 10 min. 3-Bromo-
2-methylpropene (1.36 mL, 13.5 mmol) in THF (6 mL) was added dropwise and the solution
was stirred for a further 30 min before warming to −10  over 3 h before being quenched with
NH4Cl (50 mL). The layers were separated and the aqueous phase was extracted with Et2O (3
× 50 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo. The
crude product was purified by flash column chromatography (P.E. 40-60:EtOAc, 40:1) to yield
dioxolanone 17 as a low melting point white solid (1.26 g, 5.94 mmol, 53%).
Rf: 0.21 (PE:EtOAc, 19:1). [α]
20
D : +51.7 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ
5.17 (1H, s, HCHtBu), 4.96 (1H, m, H9A), 4.87 (1H, s, H9B), 2.53 (1H, d, J = 13.8 Hz, H7A, 2.32
(1H, d, J = 13.8 Hz, H7B, 1.83 (3H, s, Me8), 1.43 (3H, s, Me6), 0.95 (9H, s,
tBu). 13C NMR
(125 MHz, CDCl3): δ 175.8, 139.8, 116.4, 108.4, 80.5, 43.1, 34.4, 23.9, 23.2, 22.9. IR (thin film,
νmax/cm
-1): 2972, 2912, 2880, 1797, 1647, 1486, 1375, 1236, 1171, 1137, 1076, 979. HRMS
(ES+): Calculated for C12H21O3 [M+H]








To a stirred solution of predried N,O-dimethylhydroxylamine hydrochloride (6.25 g, 164 mmol)
in THF (160 mL) at −78  was added nBuLi (1.48 M in hexane, 86.5 mL, 128 mmol). The
mixture was warmed to rt for 15 min then recooled to −78 . Dioxolanone 17 (3.40 g, 16.0
mmol) in THF (10 mL) was then added and the reaction stirred for 1 h. The mixture was then
warmed to −30  and stirred for a further 30 min before being quenched with NH4Cl (100 mL).
The layers were separated and the aqueous phase was extracted with Et2O (3 × 70 mL). The
combined organic phases were dried (Na2SO4) and concentrated in vacuo. The crude product
was purified by flash column chromatography (P.E. 40-60:EtOAc, 10:1) to yield Weinreb amide
18 as a colourless oil (2.71 g, 149 mmol, 91%).
Rf: 0.15 (PE:EtOAc, 4:1). [α]
20
D : +11.4 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 4.83
(1H, s, H9A), 4.72 (1H, s, H9B), 4.28 (1H, s, HO6), 3.72 (3H, s, OMe), 3.25 (3H, s, NMe), 2.68
(1H, d, J = 13.8 Hz, H7A), 2.38 (1H, d, J = 13.8 Hz, H7B), 1.75 (3H, s, Me8), 1.48 (3H, s,
Me6).
13C NMR (125 MHz, CDCl3): δ 176.8, 142.1, 114.1, 75.1, 60.8, 46.6, 33.8, 25.8, 24.2.
IR (thin film, νmax/cm
-1): 3416, 2971, 1638, 1460, 1353, 1175, 1100, 996, 894. HRMS (ES+):
Calculated for C9H18NO3 [M+H]








To a solution of alcohol 18 (2.70 g, 14.4 mmol) in CH2Cl2 (100 mL) was added Et3N (5.00
mL, 36.1 mmol) and TMSCl (3.66 mL, 28.8 mmol). The reaction was stirred for 48 h before
being quenched with NaHCO3 (70 mL). The layers were separated and the aqueous phase was
extracted with CH2Cl2 (3 × 50 mL). The combined organic phases were dried (Na2SO4) and
concentrated in vacuo. The crude product was purified by flash column chromatography (P.E.
40-60:EtOAc, 20:1) to yield TMS ether S4 as a colourless oil (3.63 g, 14.0 mmol, 97%).
Rf: 0.38 (PE:EtOAc, 4:1). [α]
20
D : +16.1 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 4.84
(1H, m, H9A), 4.72 (1H, s, H9B), 3.70 (3H, s, MeO), 3.31 (3H, br s, MeN), 2.55 (1H, d, J = 13.5
Hz, H7A), 2.48 (1H, d, J = 13.5 Hz, H7B), 1.75 (3H, s, Me8), 1.52 (3H, s, Me6), 0.16 (9H, s,
TMS). 13C NMR (125 MHz, CDCl3): δ 174.2, 141.8, 114.6, 79.4, 60.4, 48.3, 35.6, 26.4, 23.9,
2.2. IR (thin film, νmax/cm
-1): 2953, 1663, 1452, 1373, 1247, 1179, 1120, 1003, 842. HRMS
(ES+): Calculated for C12H26NO3Si [M+H]








To a solution of Weinreb amide S4 (3.60 g, 13.9 mmol) in THF (100 mL) at 0  was added
nPrMgBr (63 mL, 1.1 M in THF, 69.4 mmol). The mixture was warmed to rt for 24 h before
being quenched with NH4Cl (70 mL). The layers were separated and the aqueous phase was
extracted with Et2O (3 × 50 mL). The combined organic phases were dried (MgSO4) and
concentrated in vacuo. The crude product was purified by flash column chromatography (P.E.
40-60:EtOAc, 30:1) to yield propyl ketone 19 as a colourless oil (2.95 g, 12.0 mmol, 86%).
Rf: 0.80 (PE:EtOAc, 4:1). [α]
20
D : +1.7 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 4.79
(1H, s, H9A), 4.63 (1H, s, H9B), 2.56 (2H, t, J = 7.1 Hz, H4), 2.50 (1H, d, J = 13.7 Hz, H7A),
2.19 (1H, d, J = 13.7 Hz, H7B), 1.72 (3H, s, Me8), 1.54 (2H, app sex, J = 7.5 Hz, H24), 1.35
(3H, s, Me6), 0.90 (3H, t, J = 7.5 Hz, H25), 0.16 (9H, s, TMS).
13C NMR (125 MHz, CDCl3):
δ 215.3, 141.7, 114.5, 83.1, 48.6, 39.3, 26.0, 24.2, 16.8, 13.8, 2.3. IR (thin film, νmax/cm
-1):
2958, 1716, 1645, 1453, 1369, 1250, 1120, 1036, 888, 836, 751. HRMS (ES+): Calculated for
C13H27NO2Si [M+H]











To a solution of LDA (0.86 mmol) in THF (12 mL) at −78  was added ketone 19 (700 mg, 2.89
mmol) in THF (6 mL). The reaction was stirred for 45 min before dropwise addition of aldehyde
20 (971 mg, 4.33 mmol) in THF (6 mL). The reaction was stirred for a further 3 h before being
quenched with NH4Cl (10 mL). The layers were separated and the aqueous phase was extracted
with Et2O (3 × 10 mL). The combined organics were dried (MgSO4) and concentrated in vacuo.
The crude product was purified by flash column chromatography (P.E. 40-60:EtOAc, 10:1) to
yield aldol adduct S5 as a colourless oil (952 mg, 2.04 mmol, 71%, 4:1 dr).
Rf: 0.21 (PE:EtOAc, 4:1). [α]
20
D : +4.0 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 6.84
(3H, m, HDMB Ar-H ), 4.82 (1H, s, H9A), 4.71 (1H, s, H9B), 4.45 (2H, s, HDMB ArCH2O), 4.08 (1H,
ddd, J = 9.8, 4.8, 2.4 Hz, H3), 3.88 (3H, s, MeODMB), 3.87 (3H, s, MeODMB), 3.64 (2H, m,
H1), 3.23 (1H, ddd, J = 7.0, 4.8, 4.8 Hz, H4), 3.07 (1H, d, J = 2.3 Hz, HO3), 2.58 (1H, d,
J = 14.0 Hz, H7A, 2.21 (1H, d, J = 14.0 Hz, H7B, 1.76 (2H, m, H24A,2A), 1.75 (3H, s, Me8),
1.67 (1H, m, H2B), 1.60 (1H, m, H24B), 1.37 (3H, s, Me6), 0.87 (3H, t, J = 7.5 Hz, H25), 0.19
(9H, s, TMS). 13C NMR (125 MHz, CDCl3): δ 217.4, 149.0, 148.6, 141.3, 130.6, 120.3, 115.3,
111.0, 110.9, 83.9, 73.2, 70.2, 68.7, 55.9, 55.8, 51.7, 47.5, 34.6, 26.8, 24.7, 19.0, 12.0, 2.5. IR
12
(thin film, νmax/cm
-1): 3743, 3960, 1703, 1517, 1261, 1031, 843. HRMS (ES+): Calculated
for C25H42O6SiNa [M+Na]












To a solution of aldol adduct S5 (820 mg, 1.76 mmol) in MeCN (36 mL) was added tetrabuty-
lammonium iodide (30 mg, 0.09 mmol), DIPEA (1.53 mL, 8.79 mmol) and PMBMCl (1.28 mL,
70% by weight, 5.27 mmol). The reaction was heated under reflux for 12 h before being quenched
with NaHCO3 (20 mL). The layers were separated and the aqueous phase was extracted with
Et2O (3 × 20 mL). The combined organic phases were dried (MgSO4) and concentrated in
vacuo. The crude product was purified by flash column chromatography (P.E. 40-60:EtOAc,
10:1) to yield PMBM ether 21 as a colourless oil (1.01 g, 1.64 mmol, 93%).
Rf: 0.27 (PE:EtOAc, 4:1). [α]
20
D : +18.8 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ
7.23 (2H, d, J = 8.6 Hz, HPMBM Ar-H ), 6.85 (2H, d, J = 8.6 Hz, HPMBM Ar-H ), 6.83 (3H, m,
HDMB Ar-H ), 4.79 (1H, s, H9A), 4.71 (1H, s, H9B), 4.68 (1H, d, J = 7.0 Hz, HPMBM acetal A), 4.66
(1H, d, J = 7.0 Hz, HPMBM acetal B), 4.50 (1H, d, J = 11.5 Hz, HPMBM ArCH2O), 4.46 (1H, d,
J = 11.5 Hz, HPMBM ArCH2O), 4.40 (2H, s, HDMB ArCH2O), 4.15 (1H, dt, J = 8.4, 4.1 Hz, H3),
3.88 (3H, s, MeODMB), 3.85 (3H, s, MeODMB), 3.79 (3H, s, MeOPMBM), 3.55 (2H, m, H1), 3.25
(1H, dt, J = 7.5, 4.4 Hz, H4), 2.57 (1H, d, J = 14.0 Hz, H7A), 2.21 (1H, d, J = 14.0 Hz, H7B),
1.90 (2H, m, H2), 1.83 (1H, dt, J = 14.2, 7.1 Hz, H24A), 1.75 (3H, s, Me8), 1.57 (1H, m, H24B),
1.40 (3H, s, Me6), 0.84 (3H, t, J = 7.5 Hz, H25), 0.19 (9H, s, TMS).
13C NMR (125 MHz,
CDCl3): δ 215.8, 159.2, 149.0, 148.5, 141.3, 131.1, 130.0, 129.5, 115.4, 113.7, 111.1, 110.8, 93.9,
84.1, 74.5, 72.8, 69.4, 66.9, 55.9, 55.8, 55.3, 51.3, 48.1, 34.3, 27.4, 24.8, 19.2, 12.3, 2.5. IR (thin
film, νmax/cm
-1): 2959, 1708, 1612, 1515, 1463, 1368, 1250, 1158, 1097, 1031, 843. HRMS
(ES+): Calculated for C34H52O8SiNa [M+Na]












To a solution of DMB ether 21 (1.01 g, 1.64 mmol) in CH2Cl2/pH 7 buffer (30 mL, 9:1 v/v)
at 0  was added DDQ (410 mg, 1.81 mmol). The reaction was carefully monitored via TLC
analysis. Upon completion, the reaction mixture was quenched with NaHCO3 (20 mL) and
stirred vigorously for 1 h at rt. The layers were separated and the aqueous phase was extracted
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with CH2Cl2 (3 × 20 mL). The combined organic phases were dried (MgSO4) and concentrated
in vacuo. The crude product was purified by flash column chromatography (CH2Cl2 then P.E.
40-60:EtOAc, 3:1) to yield primary alcohol 22 as a colourless oil (650 mg, 1.39 mmol, 85%).
Rf: 0.08 (PE:EtOAc, 4:1). [α]
20
D : +36.8 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 7.25
(2H, d, J = 8.6 Hz, HPMBM Ar-H ), 6.87 (2H, d, J = 8.6 Hz, HPMBM Ar-H ), 4.80 (1H, s, H9A), 4.73
(1H, d, J = 6.8 Hz, HPMBM acetal A), 4.71 (1H, s, H9B), 4.66 (1H, d, J = 6.8 Hz, HPMBM acetal B),
4.62 (1H, d, J = 11.6 Hz, HPMBM ArCH2O), 4.47 (1H, d, J = 11.6 Hz, HPMBM ArCH2O), 4.16
(1H, dt, J = 8.0, 4.6 Hz, H3), 3.80 (3H, s, MeOPMBM), 3.80 (1H, m, H1A), 3.73 (1H, m, H1B),
3.27 (1H, dt, J = 7.3, 4.6 Hz, H4), 2.56 (1H, d, J = 13.9 Hz, H7A), 2.40 (1H, t, J = 5.7 Hz,
HO1), 2.21 (1H, d, J = 13.9 Hz, H7B), 1.82 (2H, m, H2), 1.78 (1H, m, H24A), 1.75 (3H, s, Me8),
1.50 (1H, m, H24B), 1.41 (3H, s, Me6), 0.84 (3H, t, J = 7.5 Hz, H25), 0.21 (9H, s, TMS).
13C
NMR (125 MHz, CDCl3): δ 216.2, 159.3, 141.2, 129.5, 129.4, 115.5, 113.9, 94.4, 84.2, 75.8,
69.8, 59.7, 55.3, 51.0, 48.0, 36.3, 27.3, 24.7, 19.4, 12.3, 2.6. IR (thin film, νmax/cm
-1): 3490,














To a solution of (COCl)2 (0.239 mL, 2.78 mmol) in CH2Cl2 (24 mL) at −78  was added
DMSO (0.396 mL, 5.57 mmol) and the reaction was stirred for 30 min. A solution of primary
alcohol 22 (650 mg, 1.39 mmol) in CH2Cl2 (6 mL) was added and the reaction stirred for 45
min. Et3N (1.16 mL, 8.34 mmol) was then added and the reaction stirred for 45 min before
being warmed to rt and stirred for a further 30 min. The reaction was then quenched with
NH4Cl (20 mL). The layers were separated and the aqueous phase was extracted with CH2Cl2
(3 × 20 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo.
The crude product was purified by flash column chromatography (P.E. 40-60:EtOAc, 20:1) to
yield aldehyde S6 as a colourless oil (542 mg, 2.36 mmol, 85%).
Rf: 0.46 (PE:EtOAc, 4:1). [α]
20
D : +19.0 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 9.79
(1H, dd, J = 2.9, 1.3 Hz, H1), 7.25 (2H, d, J = 8.6 Hz, HPMBM Ar-H ), 6.87 (2H, d, J = 8.6 Hz,
HPMBM Ar-H ), 4.81 (1H, s, H9A), 4.74 (2H, s, HPMBM acetal), 4.71 (1H, s, H9B), 4.52 (1H, d, J
= 11.5 Hz, HPMBM ArCH2O), 4.51 (1H, m, H3), 4.42 (1H, d, J = 11.5 Hz, HPMBM ArCH2O), 3.80
(3H, s, MeOPMBM), 3.42 (1H, dt, J = 5.8, 5.8 Hz, H4), 2.74 (1H, ddd, J = 16.7, 7.6, 3.0 Hz,
H2A), 2.63 (1H, ddd, J = 16.7, 3.7, 1.3 Hz, H2B), 2.61 (1H, d, J = 14.0 Hz, H7A), 2.22 (1H, d,
J = 14.0 Hz, H7B), 1.81 (1H, ddq, J = 14.2, 7.1, 7.1 Hz, H24A), 1.75 (3H, s, Me8), 1.49 (1H,
ddq, J = 14.2, 8.0, 7.5 Hz, H24B), 1.38 (3H, s, Me6), 0.87 (3H, t, J = 7.5 Hz, H25), 0.22 (9H, s,
TMS). 13C NMR (125 MHz, CDCl3): δ 215.7, 201.2, 159.3, 141.3, 129.5, 129.5, 115.4, 113.8,
94.0, 84.3, 72.7, 69.6, 55.3, 50.1, 47.6, 47.3, 27.1, 24.8, 20.1, 11.6, 2.5. IR (thin film, νmax/cm
-1):















To a solution of aldehyde S6 (542 mg, 1.17 mmol) in tBuOH (20 mL) was added 2-methyl-2-
butene (1.50 mL, 14.0 mmol). To this mixture was added a solution of NaClO2 (80% by weight,
400 mg, 3.5 mmol) and NaH2PO4·2 H2O (1.10 g, 7.00 mmol) in H2O (10 mL). The reaction
was stirred for 2 h before being diluted with brine (10 mL) and CH2Cl2 (20 mL). The layers
were separated and the aqueous phase was extracted with CH2Cl2 (3 × 20 mL). The combined
organic phases were dried (Na2SO4) and concentrated in vacuo to yield carboxylic acid 6 as a
colourless oil (572 mg, 1.16 mmol, 99%).
Rf: 0.46 (PE:EtOAc, 4:1). [α]
20
D : +13.6 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 7.23
(2H, d, J = 8.4 Hz, HPMBM Ar-H ), 6.85 (2H, d, J = 8.4 Hz, HPMBM Ar-H ), 4.80 (1H, s, H9A),
4.76 (1H, d, J = 7.0 Hz, HPMBM acetal A), 4.72 (1H, d, J = 7.0 Hz, HPMBM acetal B), 4.70 (1H,
s, H9B), 4.54 (1H, d, J = 11.8 Hz, HPMBM ArCH2O), 4.45 (1H, d, J = 11.8 Hz, HPMBM ArCH2O),
4.43 (1H, m, H3), 3.79 (3H, s, MeOPMBM), 3.44 (1H, dt, J = 5.7, 5.7 Hz, H4), 2.69 (1H, dd, J
= 15.9, 4.0 Hz, H2A), 2.63 (1H, dd, J = 15.9, 7.1 Hz, H2B), 2.81 (1H, d, J = 13.8 Hz, H7A), 2.22
(1H, d, J = 13.8 Hz, H7B), 1.82 (1H, ddq, J = 12.4, 6.2, 6.2 Hz, H24A), 1.75 (3H, s, Me8), 1.51
(1H, m, H24B), 1.39 (3H, s, Me6), 0.85 (3H, t, J = 7.4 Hz, H25), 0.21 (9H, s, TMS).
13C NMR
(125 MHz, CDCl3): δ 215.6, 175.9, 159.2, 141.4, 129.7, 129.6, 115.4, 113.8, 94.0, 84.4, 74.0,
69.6, 55.3, 50.1, 47.7, 38.5, 27.2, 24.8, 19.7, 11.7, 2.5. IR (thin film, νmax/cm
-1): 2960, 1736,




















To a solution of carboxylic acid 6 (400 mg, 0.832 mmol) in toluene (10 mL) at 0  was added
Et3N (0.176 mL, 1.25 mmol) and 2,4,6-trichlorobenzoyl chloride (0.168 mL, 1.08 mmol). The
reaction was stirred at rt for 6 h before addition of a solution of alcohol 7 (511 mg, 0.749 mmol)
and DMAP (184 mg, 1.50 mmol) in toluene (6 mL). The reaction was stirred for 72 h then
quenched with H2O (10 mL). The layers were separated and the aqueous phase was extracted
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with Et2O (3 × 20 mL). The combined organic phases were dried (MgSO4) and concentrated
in vacuo. The crude product was purified by flash column chromatography (P.E. 40-60:EtOAc,
30:1) to yield ester S7 as a colourless oil (883 mg, 99%).
Rf: 0.74 (PE:EtOAc, 4:1). [α]
20
D : +5.0 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 7.26
(4H, m, HPMBM and PMB Ar-H ), 6.86 (4H, m, HPMBM and PMB Ar-H ), 5.68 (1H, dddd, J = 16.0,
9.4, 7.1, 7.1 Hz, H9), 5.10 (1H, t, J = 6.6 Hz, H11), 5.01 (1H, d, J = 16.0 Hz, H8’A), 4.98 (1H,
d, J = 9.4 Hz, H8’B), 4.88 (1H, d, J = 9.9 Hz, H17), 4.80 (1H, s, H9’A), 4.72 (1H, s, H9’B), 4.72
(2H, s, HPMBM acetal), 4.51 (1H, d, J = 11.6 Hz, HPMBM ArCH2O), 4.50 (1H, m, H3), 4.44 (1H, d,
J = 11.6 Hz, HPMBM ArCH2O), 4.43 (1H, d, J = 11.5 Hz, HPMB ArCH2O), 4.38 (1H, d, J = 11.5
Hz, HPMB ArCH2O), 3.80 (3H, s, MeOPMB), 3.79 (3H, s, MeOPMBM), 3.55 (1H, dd, J = 8.2, 1.4
Hz, H19), 3.44 (1H, m, H4), 3.41 (1H, m, H13), 3.35 (1H, dd, J = 8.6, 7.1 Hz, H21A), 3.19 (1H,
dd, J = 8.6, 7.1 Hz, H21B), 2.61 (2H, m, H2), 2.61 (1H, d, J = 13.8 Hz, H7A), 2.47 (1H, m,
H18), 2.42 (1H, m, H10A), 2.24 (1H, d, J = 13.8 Hz, H7B), 2.19 (1H, m, H10B), 2.06 (1H, d, J =
12.0 Hz, H15A), 1.94 (1H, qd, J = 6.9, 1.2 Hz, H20), 1.81 (1H, m, 24A), 1.75 (3H, s, Me8), 1.75
(1H, m, H12), 1.75 (1H, m, H14), 1.69 (1H, m, H15B), 1.55 (3H, s, Me16), 1.43 (1H, m, 24B), 1.41
(3H, s, Me6), 0.95 (18H, t, J = 8.0 Hz, SiCH2CH3), 0.93 (3H, d, J = 6.0 Hz, Me18), 0.88 (3H, t,
J = 7.4 Hz, H25), 0.87 (3H, d, J = 7.0 Hz, Me12), 0.82 (3H, d, J = 7.0 Hz, Me20), 0.77 (3H, d,
J = 6.2 Hz, Me14), 0.62 (6H, q, J = 8.0 Hz, SiCH2CH3), 0.60 (6H, q, J = 8.0 Hz, SiCH2CH3),
0.22 (9H, s, TMS). 13C NMR (125 MHz, CDCl3): δ 215.7, 171.3, 159.1, 159.1, 141.5, 134.0,
132.3, 130.8, 130.3, 130.0, 129.6, 129.3, 117.4, 115.2, 113.7, 113.7, 93.9, 84.2, 78.5, 77.1, 73.9,
73.6, 73.5, 72.5, 69.4, 55.3, 55.3, 50.1, 47.7, 40.4, 39.2, 38.4, 37.1, 37.0, 36.9, 33.6, 27.1, 24.8,
20.1, 18.2, 16.8, 15.9, 12.1, 10.9, 10.5, 7.2, 7.1, 5.5, 5.5, 2.5. IR (thin film, νmax/cm
-1): 2957,
2876, 1731, 1715, 1613, 1514, 1458, 1369, 1248, 1181, 1098, 1036, 842, 737. HRMS (ES+):
Calculated for C64H114O11Si3N [M+NH4]
















To a refluxing solution of ester S7 (455 mg, 0.399 mmol) in thoroughly degassed (4 cycles of
freeze-pump-thawing) toluene (500 mL) was added Hoveyda-Grubbs second generation catalyst
(100 mg, 0.159 mmol) as a solution in degassed toluene (24 mL) in 3 portions over 3 days. After
the first addition, the mixture was purged with argon to remove the ethene byproduct. The
reaction was heated at reflux for a further 4 days before being filtered over a short plug of silica.
The crude product was purified by flash column chromatography (P.E. 40-60:EtOAc, 20:1) to
yield macrocycle S8 as a colourless oil, inseparable from the byproduct formed by dimerisation
of the terminal alkene. An analytically pure sample was not obtained at this stage as the C9
homodimer was inseparable from the macrocycle S8. Confirmation of S8 was made in the
subsequent step after PMB and PMBM deprotection.
The presence of the macrocycle in the crude mixture was confirmed by changes in the alkene
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To a solution of crude macrocycle S8 (58.0 mg, 0.050 mmol) in 9:1 CH2Cl2/pH 7 buffer (2
mL) at 0  was added DDQ (47.5 mg, 0.209 mmol). The reaction was warmed to rt and
stirred for 1 h. When TLC analysis indicated that the reaction had gone to completion, it
was quenched with NaHCO3 (2 mL) and stirred vigorously for 1 h. The layers were separated
and the aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The combined organic phases
were dried (MgSO4) and concentrated in vacuo. THe filtrate was concentrated under reduced
pressure and the crude product was purified by flash column chromatography (CH2Cl2 then
P.E. 40-60:EtOAc, 15:1) to yield diol 23 as a colourless oil (35 mg, 0.0419 mmol, 70% over 2
steps).
Rf: 0.56 (PE:EtOAc, 4:1). [α]
20
D : −68.2 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ 5.35
(1H, dt, J = 11.7, 3.2 Hz, H11), 5.09 (1H, d, J = 10.8 Hz, H9), 4.89 (1H, d, J = 9.5 Hz, H17),
4.07 (1H, dddd, J = 8.7, 4.8, 3.6, 3.6 Hz, H3), 3.65 (1H, d, J = 4.8 Hz, HO3), 3.58 (1H, m,
H19), 3.58 (1H, m, H21A), 3.47 (1H, m, H21B), 3.38 (1H, dd, J = 4.5, 5.3 Hz, H13), 2.83 (1H,
dt, J = 5.5, 3.9 Hz, H4), 2.61 (2H, m, H7), 2.55 (1H, m, H18), 2.50 (2H, m, H2), 2.50 (1H, m,
H10A), 2.17 (1H, dd, J = 12.2, 2.4 Hz, H15A), 1.95 (1H, m, H10B), 1.88 (1H, m, H20), 1.88 (1H,
m, H24A), 1.83 (1H, t, J = 5.4 Hz, HO21), 1.82 (1H, m, H24B), 1.79 (1H, m, H14), 1.76 (1H, m,
H12), 1.63 (1H, dd, J = 12.2, 11.4 Hz, H15B), 1.58 (3H, s, Me16), 1.57 (3H, s, Me8), 1.43 (3H, s,
Me6), 1.00 (3H, t, J = 7.6 Hz, H25), 0.98 (9H, t, J = 7.9 Hz, SiCH2CH3), 0.96 (9H, t, J = 7.9
Hz, SiCH2CH3), 0.96 (3H, d, J = 6.3 Hz, Me18), 0.95 (3H, d, J = 3.7 Hz, Me12), 0.82 (3H, d,
J = 7.1 Hz, Me20), 0.78 (3H, d, J = 6.8 Hz, Me14), 0.64 (6H, q, J = 8.0 Hz, SiCH2CH3), 0.64
(6H, q, J = 8.0 Hz, SiCH2CH3), 0.14 (9H, s, TMS).
13C NMR (125 MHz, CDCl3): δ 217.2,
171.5, 134.9, 132.4, 130.5, 125.5, 83.5, 79.3, 77.9, 73.3, 68.7, 66.3, 52.9, 49.5, 41.8, 41.0, 40.0,
39.2, 36.4, 34.5, 33.5, 28.5, 19.9, 18.3, 16.4, 16.0, 15.1, 12.6, 12.3, 11.3, 7.1, 7.1, 5.5, 5.4, 2.7. IR
(thin film, νmax/cm
-1): 2956, 2877, 1733, 1705, 1459, 1416, 1381, 1247, 1182, 1095, 1019, 974,
842, 736. HRMS (ES+): Calculated for C45H88O8Si3K [M+K]


















To a solution of primary alcohol S8 (24.2 mg, 0.0290 mmol) in CH2Cl2 (2 mL) was added
bis(acetoxy)iodobenzene (13.9 mg, 0.0430 mmol) and TEMPO (1.8 mh, 0.0120 mmol). The
reaction was stirred for 4 h before being quenched with NaHCO3/Na2S2O3 (2 mL, 1:1 v/v) and
stirred vigorously for 1 h. The layers were separated and the aqueous phase was extracted with
CH2Cl2 (3 × 5 mL). The combined organics were dried (MgSO4) and concentrated in vacuo.
The crude product was purified by flash column chromatography (P.E. 40-60:EtOAc, 20:1) to
yield aldehyde 24 as a colourless oil (21.7 mg, 90%).
Rf: 0.78 (PE:EtOAc, 4:1). [α]
20
D : −39.1 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ 9.73
(1H, s, H21), 5.35 (1H, dt, J = 11.6, 2.6 Hz, H11), 5.09 (1H, d, J = 10.0 Hz, H9), 4.90 (1H, d,
J = 9.8 Hz, H17), 4.07 (1H, dddd, J = 7.9, 4.3, 3.7, 3.7 Hz, H3), 3.98 (1H, dd, J = 8.1, 2.2 Hz,
H19), 3.66 (1H, d, J = 5.0 Hz, HO3), 3.38 (1H, dd, J = 4.7, 4.7 Hz, H13), 2.83 (1H, dt, J = 4.0,
4.0 Hz, H4), 2.61 (2H, m, H7), 2.55 (1H, m, H18), 2.50 (2H, m, H2), 2.50 (1H, m, H10A), 2.48
(1H, m, H20), 2.18 (1H, d, J = 12.7 Hz, H15A), 1.95 (1H, m, H10B), 1.89 (1H, m, H24A), 1.80
(1H, m, H24B), 1.79 (1H, m, H14), 1.76 (1H, m, H12), 1.64 (1H, dd, J = 12.7, 11.9 Hz, H15B),
1.58 (3H, s, Me16), 1.57 (3H, s, Me8), 1.43 (3H, s, Me6), 1.09 (3H, d, J = 7.0 Hz, Me20), 1.01
(3H, t, J = 7.5 Hz, H25), 0.98 (3H, d, J = 6.6 Hz, Me18), 0.97 (9H, t, J = 7.9 Hz, SiCH2CH3),
0.95 (9H, t, J = 7.9 Hz, SiCH2CH3), 0.95 (3H, m, Me12), 0.78 (3H, d, J = 6.7 Hz, Me14), 0.64
(6H, q, J = 8.0 Hz, SiCH2CH3), 0.59 (6H, q, J = 8.0 Hz, SiCH2CH3), 0.14 (9H, s, TMS).
13C
NMR (125 MHz, CDCl3): δ 217.3, 205.5, 171.5, 134.9, 134.2, 129.5, 125.5, 83.6, 79.3, 75.7,
73.2, 68.7, 52.9, 51.2, 49.5, 41.8, 41.0, 39.2, 37.3, 34.3, 33.5, 28.6, 19.9, 17.8, 16.4, 16.1, 15.2,
12.6, 12.2, 7.5, 7.1, 7.0, 5.5, 5.3, 2.8. IR (thin film, νmax/cm
-1): 2959, 1731, 1702, 1708, 1458,



















To a solution of aldehyde 24 (3.7 mg, 4.4 µmol) in Et2O (0.5 mL) at −78  was added EtMgBr
(22 µL, 0.8M in Et2O, 18 µmol). The reaction was allowed to warm to −40  and maintained
at that temperature for 30 min. The mixture was then recooled to −78  and quenched
with MeOH (0.1 mL) then NH4Cl (1 mL). The layers were separated and the aqueous phase
was extracted with Et2O (3 × 1 mL). The combined organic phases were dried (MgSO4) and



















To a solution of diol S9 (20.0 mg, 23.8 µmol) in CH2Cl2 (5 mL) was added NaHCO3 (23.8 mg,
283 µmol) then Dess-Martin periodinane (60.0 mg, 142 µmol) and the reaction was stirred for
18 h. The reaction was then quenched with NaHCO3 (2 mL) and Na2S2O3 (2 mL). The layers
were separated and the aqueous phase was extracted with Et2O (3 × 5 mL). The combined
organic phases were dried (Na2SO4) and concentrated in vacuo. The crude product was purified
by flash column chromatography on florisil (P.E. 40-60:EtOAc, 40:1) to yield triketone 25 as a
colourless oil (18.7 mg, 21.6 µmol, 91% over 2 steps).
Rf: 0.82 (PE:EtOAc, 4:1). [α]
20
D : −64.9 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ 5.23
(1H, dt, J = 11.1, 3.8 Hz, H11), 5.18 (1H, dd, J = 9.3, 6.0 Hz, H9), 4.89 (1H, d, J = 9.6 Hz,
H17), 4.05 (1H, t, J = 6.9 Hz, H4), 3.88 (1H, dd, J = 6.5, 4.9 Hz, H19), 3.51 (1H, d, J = 17.9
Hz, H2A), 3.38 (1H, dd, J = 4.8, 4.8 Hz, H13), 3.23 (1H, d, J = 17.9 Hz, H2B), 2.68 (1H, d, J
= 13.9 Hz, H7A), 2.62 (1H, m, H20), 2.46 (2H, qd, J = 7.0, 2.5 Hz, H22), 2.38 (1H, m, H10A),
2.37 (1H, m, H18), 2.27 (1H, d, J = 13.9 Hz, H7B), 2.20 (1H, d, J = 12.9 Hz, H15A), 2.09 (1H,
m, H24A), 2.08 (1H, m, H10B), 1.77 (1H, m, H24B), 1.77 (1H, m, H14), 1.77 (1H, m, H12), 1.69
(3H, s, Me8), 1.58 (1H, d, J = 12.9 Hz, H15B), 1.54 (3H, s, Me16), 1.45 (3H, s, Me6), 1.08 (3H,
d, J = 7.0 Hz, Me20), 1.02 (3H, t, J = 7.3 Hz, H23), 0.97 (3H, d, J = 7.4 Hz, Me12), 0.96 (3H,
d, J = 7.6 Hz, Me18), 0.95 (18H, t, J = 7.6 Hz, SiCH2CH3), 0.91 (3H, t, J = 7.4 Hz, H25),
0.75 (3H, d, J = 6.9 Hz, Me14), 0.59 (12H, q, J = 7.6 Hz, SiCH2CH3), 0.19 (9H, s, TMS).
13C NMR (125 MHz, CDCl3): δ 214.0, 209.0, 198.0, 167.3, 134.8, 133.5, 130.5, 126.3, 85.5,
79.4, 77.1, 74.4, 64.8, 50.5, 49.5, 47.4, 42.3, 41.4, 37.6, 35.0, 34.1, 33.1, 28.8, 21.9, 18.3, 16.8,
16.3, 15.9, 12.3, 12.2, 12.0, 7.7, 7.1, 7.1, 5.4, 5.3, 2.3. IR (thin film, νmax/cm
-1): 2956, 1878,
1737, 1726, 1713, 16941459, 1380, 1320, 1251, 1159, 1097, 1010, 976, 843, 737. HRMS (ES+):
Calculated for C47H92O8Si3N [M+NH4]

















To a solution of triketone 25 (1.5 mg, 1.7 µmol) in THF (0.2 mL) at 0 was added pyridine:HF·pyridine
(100 µL, 3:1 v/v, 960 µmol). The reaction was warmed to 40  and stirred for 2 h. The re-
action was then quenched with NaHCO3 (1 mL) followed by addition of solid NaHCO3 until
effervescence ceased. The layers were separated and the aqueous phase was extracted with Et2O
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(3 × 1 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo. The
crude product was purified by flash column chromatography (P.E. 40-60:EtOAc, 2:1) to yield
actinoallolide A (1) as a colourless oil (1.0 mg, 1.7 µmol, 99%).
Rf: 0.46 (PE:EtOAc, 1:1). [α]
20
D : +100.3 (c 0.1, MeOH), (lit. = +105.2 °)
1. 1H NMR (400
MHz, CDCl3): δ 5.40 (1H, ddd, J = 7.1, 7.1, 1.8 Hz, H11), 5.13 (1H, dd, J = 7.8, 7.8 Hz, H9),
4.88 (1H, d, J = 9.8 Hz, H17), 3.64 (1H, ddd, J = 9.4, 2.3, 2.3 Hz, H19), 3.26 (1H, ddd, J =
9.2, 4.9, 2.5 Hz, H13), 2.91 (1H, d, J = 12.0 Hz, H2A), 2.83 (1H, dd, J = 7.6, 5.5 Hz, H4),
2.77 (1H, d, J = 12.0 Hz, H2B), 2.67 (1H, qd, J = 7.3, 2.2 Hz, H20), 2.52 (1H, m, H22A), 2.50
(1H, m, H10A), 2.46 (1H, m, H18), 2.44 (1H, m, H22B), 2.34 (1H, m, H10B), 2.36 (1H, d, J =
13.4 Hz, H7A), 2.30 (1H, d, J = 13.4 Hz, H7B), 2.13 (1H, d, J = 11.0 Hz, H15A), 1.84 (1H, m,
H24A), 1.83 (1H, m, H14), 1.78 (1H, m, H12), 1.78 (1H, m, H15B), 1.63 (3H, s, Me16), 1.61 (1H,
m, H24B), 1.47 (3H, s, Me8), 1.34 (3H, s, Me6), 1.14 (3H, t, J = 7.5 Hz, H25), 1.07 (3H, d, J
= 7.0 Hz, Me20), 1.05 (3H, d, J = 6.4 Hz, Me18), 1.05 (3H, t, J = 7.5 Hz, H23), 1.01 (3H, d,
J = 7.0 Hz, Me12), 0.89 (3H, d, J = 6.6 Hz, Me14).
13C NMR (125 MHz, CDCl3): δ 217.7,
217.3, 170.2, 133.7, 131.7, 128.8, 126.5, 102.3, 82.1, 76.6, 74.9, 73.6, 53.3, 48.9, 47.5, 46.7, 40.6,
38.8, 35.9, 34.8, 32.2, 29.9, 26.8, 18.7, 17.9, 17.2, 16.9, 16.1, 12.1, 10.2, 9.4, 7.7. IR (thin film,
νmax/cm
-1): 2926, 1704, 1455, 1314, 1147, 977. HRMS (ES+): Calculated for C32H52O8Na

















To a solution of actinoallolide A (1) (4.0 mg, 7.1 µmol) in THF (1 mL) was added triethylborane
(31 µL, 1M solution in hexane, 31 µmol). After streaming of air (2 mL), the reaction was stirred
for 2 h then cooled to −78  before addition of NaBH4 (3.4 mg, 71 µmol), followed after 1
h by MeOH (0.25 mL). The reaction was stirred for a further 4 h before warming to rt. The
reaction was then quenched with pH 7 buffer/30% H2O2/MeOH (1 mL, 1:1:1 v/v) and stirred
for a further 30 min. After dilution with NH4Cl (1 mL), the layers were separated and the
aqueous phase was extracted with CH2Cl2 (3 × 2 mL). The combined organic phases were
dried (Na2SO4) and concentrated in vacuo. The crude product was purified by flash column
chromatography on florisil (P.E. 40-60:EtOAc, 3:1) to yield actinoallolide B (2) as a colourless
oil (4.0 mg, 7.1 µmol, 99%).
Rf: 0.39 (PE:EtOAc, 1:1). [α]
20
D : +82.0 (c 0.1, MeOH), (lit. = +102.7 °)
1. 1H NMR (400
MHz, CDCl3): δ 5.39 (1H, ddd, J = 7.9, 7.9, 1.8 Hz, H11), 5.13 (1H, dd, J = 7.5, 7.5 Hz, H9),
4.88 (1H, d, J = 9.9 Hz, H17), 3.71 (1H, dd, J = 7.2, 6.2 Hz, H21), 3.52 (1H, d, J = 9.5 Hz,
H19), 3.26 (1H, ddd, J = 9.6, 4.9, 2.6 Hz, H13), 2.91 (1H, d, J = 12.1 Hz, H2A), 2.84 (1H, dd,
J = 7.9, 5.8 Hz, H4), 2.77 (1H, m, J = 12.1 Hz, H2B), 2.52 (1H, m, H18), 2.51 (1H, m, H10A),
2.35 (1H, m, H7A), 2.33 (1H, m, H10B), 2.29 (1H, m, H7B), 2.12 (1H, d, J = 12.4 Hz, H15A),
1.84 (1H, m, H24A), 1.82 (1H, m, H14), 1.78 (1H, m, H12), 1.77 (1H, m, H15B), 1.66 (1H, m,
20
H20), 1.63 (3H, d, J = 0.7 Hz, Me16), 1.61 (1H, m, H24B), 1.53 (1H, m, H22A), 1.47 (3H, d, J
= 0.8 Hz, Me8), 1.42 (1H, m, H22B), 1.34 (3H, s, Me6), 1.14 (3H, t, J = 7.5 Hz, H25), 1.04 (3H,
d, J = 6.6 Hz, Me18), 1.00 (3H, d, J = 7.0 Hz, Me12), 0.90 (3H, t, J = 7.4 Hz, H23), 0.88 (3H,
d, J = 6.4 Hz, Me14), 0.84 (3H, d, J = 7.1 Hz, Me20).
13C NMR (125 MHz, CDCl3): δ 217.7,
170.1, 133.2, 131.7, 129.1, 126.5, 102.3, 82.1, 82.0, 79.3, 76.6, 73.6, 53.3, 48.9, 46.7, 40.6, 38.7,
37.8, 36.8, 32.4, 29.9, 28.1, 26.8, 18.4, 17.9, 17.2, 17.0, 16.2, 12.0, 10.4, 10.3, 4.2. IR (thin film,
νmax/cm
-1): 3420, 2963, 1754, 1719, 1457, 1317, 1149, 1102, 972. HRMS (ES+): Calculated
for C32H54O8K [M+K]
















To a solution of actinoallolide B (2) (3.0 mg, 5.3 µmol) in CH2Cl2 (1 mL) at rt was added
TFA (50 µL). The reaction was stirred for 3 min and concentrated in vacuo. The crude prod-
uct was purified by flash column chromatography on florisil (P.E. 40-60:EtOAc, 3:1) to yield
actinoallolide D (4) as a colourless oil (3.0 mg, 5.3 µmol, 99%).
Rf: 0.39 (PE:EtOAc, 1:1). [α]
20
D : +108.0 (c 0.1, MeOH), (lit. = +167.7 °)
1. 1H NMR (400
MHz, CDCl3): δ 5.27 (1H, ddd, J = 7.0, 7.0, 1.3 Hz, H11), 5.16 (1H, dd, J = 7.7, 7.7 Hz, H9),
4.88 (1H, d, J = 9.8 Hz, H17), 3.71 (1H, dd, J = 6.7, 6.7 Hz, H21), 3.63 (1H, d, J = 11.4 Hz,
H2A), 3.52 (1H, d, J = 9.5 Hz, H19), 3.31 (1H, d, J = 11.4 Hz, H2B), 3.27 (1H, ddd, J = 9.0,
5.2, 2.7 Hz, H13), 2.51 (1H, m, H18), 2.49 (1H, m, H10A), 2.47 (1H, d, J = 13.2 Hz, H7A), 2.43
(1H, d, J = 13.2 Hz, H7B), 2.29 (1H, m, H10B), 2.27 (1H, m, H24A), 2.19 (1H, m, H24B), 2.12
(1H, d, J = 12.1 Hz, H15A), 1.82 (1H, m, H14), 1.79 (1H, m, H12), 1.78 (1H, m, H15B), 1.65 (1H,
m, H20), 1.63 (3H, s, Me16), 1.53 (1H, m, H22A), 1.43 (3H, s, Me8), 1.41 (1H, m, H22B), 1.41
(3H, s, Me6), 1.04 (3H, t, J = 7.2 Hz, H25), 1.04 (3H, d, J = 6.8 Hz, Me18), 1.00 (3H, d, J =
7.0 Hz, Me12), 0.90 (3H, t, J = 7.4 Hz, H23), 0.89 (3H, d, J = 6.5 Hz, Me14), 0.84 (3H, d, J =
7.1 Hz, Me20).
13C NMR (125 MHz, CDCl3): δ 206.5, 177.4, 168.3, 133.2, 130.9, 129.1, 126.2,
119.0, 87.6, 82.0, 79.3, 76.6, 76.0, 47.9, 41.1, 38.7, 37.8, 37.5, 36.8, 32.3, 29.9, 28.1, 22.2, 17.9,
17.1, 17.0, 16.2, 14.9, 12.3, 10.4, 10.4, 4.2. IR (thin film, νmax/cm
-1): 3458, 2934, 1734, 1716,
1693, 1683, 1614, 1458, 1398, 1272, 1210, 974, 958. HRMS (NSI−): Calculated for C32H51O7
[M−H]−: 547.3640, found 547.3641.
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A solution of crude actinoallolide A (as prepared from triketone 25) (2.6 mg, 4.6 µmol) in Et2O
(5 mL) was passed through a plug of alumina (Merck Aluminium oxide 90 standardised), which
afforded a mixture of actinoallolides C and E. This mixture was purified by preparatory TLC
(CHCl3/MeOH, 15:1) to yield actinoallolide C (1.3 mg, 2.3 µmol, 50%) and actinoallolide E
(1.2 mg, 2.2 µmol, 48%).
Actinoallolide C: Rf: 0.71 (PE:EtOAc, 1:1). [α]
20
D : +80.0 (c 0.1, MeOH), (lit. = +190.0
°)1. 1H NMR (400 MHz, CDCl3): δ 5.28 (1H, ddd, J = 6.9, 6.9, 1.7 Hz, H11), 5.17 (1H, dd,
J = 7.9, 7.9 Hz, H9), 4.89 (1H, d, J = 9.9 Hz, H17), 3.64 (1H, m, H19), 3.64 (1H, d, J = 11.4
Hz, H2A), 3.31 (1H, d, J = 11.4 Hz, H2B), 3.27 (1H, m, H13), 2.67 (1H, qd, J = 7.2, 2.2 Hz,
H20), 2.49 (1H, m, H10A), 2.48 (2H, m, H22), 2.46 (1H, m, H18), 2.46 (2H, m, H7), 2.31 (1H,
m, H10B), 2.23 (2H, m, H24), 2.13 (1H, d, J = 12.6 Hz, H15A), 1.84 (1H, m, H14), 1.80 (1H, m,
H12), 1.80 (1H, m, H15B), 1.63 (3H, s, Me16), 1.44 (3H, s, Me8), 1.41 (3H, s, Me6), 1.07 (3H, d,
J = 7.2 Hz, Me20), 1.05 (3H, d, J = 7.1 Hz, Me18), 1.05 (3H, t, J = 7.0 Hz, H25), 1.05 (3H,
t, J = 7.0 Hz, H23), 1.01 (3H, d, J = 7.0 Hz, Me12), 0.89 (3H, d, J = 6.4 Hz, Me14).
13C
NMR (125 MHz, CDCl3): δ 217.3, 206.5, 177.4, 168.4, 133.7, 131.0, 128.8, 126.2, 119.0, 87.6,
76.6, 76.0, 74.9, 47.9, 47.5, 41.1, 38.9, 37.6, 36.0, 34.8, 32.2, 29.9, 22.3, 17.9, 17.0, 17.0, 16.1,
14.9, 12.3, 10.4, 9.4, 7.7. IR (thin film, νmax/cm
-1): 2927, 1698, 1614, 1451, 1398, 1272, 979.
HRMS (ES+): Calculated for C32H51O7 [M+H]
+: 547.3629, found 547.3603.
Actinoallolide E: Rf: 0.62 (PE:EtOAc, 1:1). [α]
20
D : +73.0 (c 0.1, MeOH), (lit. = +120.1 °)
1.
1H NMR (400 MHz, CDCl3): δ 5.23 (1H, dd, J = 8.2, 8.2 Hz, H9), 4.97 (1H, dd, J = 9.4, 2.1
Hz, H13), 4.82 (1H, d, J = 10.0 Hz, H17), 3.82 (1H, d, J = 14.8 Hz, H2A), 3.65 (1H, d, J = 9.2
Hz, H19), 3.26 (1H, d, J = 14.8 Hz, H2B), 3.26 (1H, d, J = 8.8 Hz, H13), 2.65 (1H, qd, J = 7.2,
2.2 Hz, H20), 2.62 (1H, d, J = 13.6 Hz, H7A), 2.56 (1H, m, H22A), 2.48 (1H, m, H22B), 2.47 (1H,
m, H18), 2.47 (1H, d, J = 13.6 Hz, H7B), 2.30 (1H, m, H24A), 2.24 (1H, m, H10A), 2.22 (1H, m,
H24B), 2.13 (1H, d, J = 13.2 Hz, H15A), 1.97 (1H, m, H10B), 1.93 (1H, m, H14), 1.68 (1H, dd,
J = 13.2, 11.7 Hz, H15B), 1.63 (3H, s, Me16), 1.54 (1H, m, H12), 1.53 (3H, s, Me8), 1.36 (3H, s,
Me6), 1.11 (3H, t, J = 7.5 Hz, H25), 1.09 (3H, d, J = 7.2 Hz, Me20), 1.06 (3H, t, J = 7.3 Hz,
H23), 1.05 (3H, d, J = 6.4 Hz, Me18), 0.95 (3H, d, J = 7.2 Hz, Me12), 0.81 (3H, d, J = 6.8 Hz,
Me14).
13C NMR (125 MHz, CDCl3): δ 217.3, 207.0, 177.7, 166.7, 132.9, 130.7, 129.4, 126.6,
22
117.6, 88.2, 81.4, 74.8, 72.7, 47.5, 46.4, 40.2, 39.5, 36.0, 35.8, 35.2, 34.8, 31.6, 24.9, 17.9, 17.7,
16.5, 15.9, 15.6, 13.1, 9.5, 8.1, 7.7. IR (thin film, νmax/cm
-1): 2932, 1734, 1696, 1620, 1452,
1250, 979. HRMS (ES+): Calculated for C32H50O7Na [M+Na]
+: 547.3629, found 547.3620.
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2 Confirmation of Configuration in Stereogenic Reactions
Due to availability of reagents, initial exploratory investigations towards the side chain fragment
were performed in the opposite enantiomeric series. Thus, stereochemical proofs performed on
the relevant compounds are enantiomeric to those presented in the final synthesis
2.1 C17 Stereocentre
The configuration of the alcohol at C17 formed in the titanium-mediated aldol reaction was
determined by performing the reaction without the in situ reduction. Synthesis of the diastere-







To a stirred solution of PMB-protected (S )-Roche ester ethyl ketone (200 mg, 0.846 mmol) in
CH2Cl2 (6 mL) at −78 °C was added a solution of Ti(OiPr)Cl3 (0.931 mmol) in CH2Cl2 (4
mL). DIPEA (0.162 mL, 0.931 mmol) was added followed by a solution of methacrolein (0.20
mL, 1.27 mmol) in CH2Cl2 (4 mL) over 1.5 h. When TLC analysis indicated the reaction was
complete, it was quenched by addition of MeOH (1 mL) upon completion (20 min). Potassium
sodium tartrate solution (10 mL) was added and the mixture warmed to rt and stirred for
1 h. The phases were separated and the organic phase washed with H2O, then NaHCO3
solution and brine. The combined aqueous washings were back-extracted with CH2Cl and
the combined organic extracts dried with MgSO4, concentrated in vacuo and purified by flash
column chromatography (P.E. 40-60:EtOAc, 10:1) to give aldol adduct S10 as a colourless oil
(190 mg, 0.646 mmol, 76%).
Rf: 0.27 (PE:EtOAc, 6:1). [α]
20
D : +31.0 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3): δ 7.20
(2H, d, J = 8.6 Hz, HPMB Ar-H ), 6.86 (2H, d, J = 8.6 Hz, HPMB Ar-H ), 5.09 (1H, m, H15A),
4.93 (1H, m, H15B), 4.50 (1H, m, H17), 4.42 (1H, d, J = 11.7 Hz, HPMB ArCH2O), 4.38 (1H, d,
J = 11.7 Hz, HPMB ArCH2O), 3.80 (3H, s, MeOPMB), 3.58 (1H, dd, J = 8.8, 8.6 Hz, H21A), 3.45
(1H, dd, J = 8.6, 5.0 Hz, H21B), 3.18 (1H, d, J = 2.8 Hz, HO17), 3.16 (1H, m, H20), 2.86 (1H,
qd, J = 7.2, 2.5 Hz, H18), 1.63 (3H, s, Me16), 1.03 (3H, d, J = 6.9 Hz, Me20), 1.00 (3H, d,
J = 7.2 Hz, Me18).
13C NMR (125 MHz, CDCl3): δ 218.1, 159.3, 143.3, 129.6, 129.3, 113.8,
111.4, 73.1, 72.8, 72.5, 55.2, 48.5, 44.6, 19.6, 13.6, 8.2. IR (thin film, νmax/cm
-1): 3494 (br),
2940, 1701, 1612, 1513, 1453, 1247, 1095, 1034, 818. HRMS (ES+): Calculated for C18H27O4











To a stirred solution of aldol adduct S10 (2.0 mg, 6.8 µmol) in CH2Cl2 (0.5 mL) was added
(R)-MTPA (8.0 mg, 34 µmol), DCC (7.0 mg, 34 µmol) and DMAP (one crystal). The reaction
mixture was stirred for 18 h then the solvent was removed in vacuo. The crude product was
dissolved in ether (0.5 mL) and the resulting suspension filtered. The solvent was removed in
vacuo and the residue analysed without further purification.
Rf: 0.46 (PE:EtOAc, 6:1).
1H NMR (400 MHz, CDCl3): δ 7.51 (2H, m, HPh), 7.40 (3H, m,
HPh), 7.19 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 6.85 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 5.70 (1H,
d, J = 6.7 Hz, H17), 5.02 (1H, m, H15A), 4.96 (1H, m, H15B), 4.36 (2H, s, HPMB ArCH2O), 3.79
(3H, s, MeOPMB), 3.53 (3H, s, MeO), 3.51 (2H, ABQ, J = 11.6 Hz, H21), 3.04 (1H, m, H20),











To a stirred solution of aldol adduct S10 (2.0 mg, 6.8 µmol) in CH2Cl2 (0.5 mL) was added
(S )-MTPA (8.0 mg, 34 µmol), DCC (7.0 mg, 34 µmol) and DMAP (one crystal). The reaction
mixture was stirred for 18 h then the solvent was removed in vacuo. The crude product was
dissolved in ether (0.5 mL) and the resulting suspension filtered. The solvent was removed in
vacuo and the residue analysed without further purification.
Rf: 0.46 (PE:EtOAc, 6:1).
1H NMR (400 MHz, CDCl3): δ 7.52 (2H, m, HPh), 7.40 (3H, m,
HPh), 7.19 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 6.85 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 5.67 (1H,
d, J = 5.2 Hz, H17), 4.87 (1H, m, H15A), 4.79 (1H, m, H15B), 4.35 (2H, s, HPMB ArCH2O), 3.79
(3H, s, MeOPMB), 3.55 (3H, s, MeO), 3.52 (2H, ABQ, J = 11.6 Hz, H21), 3.03 (1H, m, H20),
















Figure 1: ∆δ (= δS − δR) values for MTPA esters S11 and S12
2.2 C18 and C19 Stereocentres
The configuration of the methyl group at C18 and the alcohol at C19 formed in the titanium-
mediated aldol/in situ reduction sequence were determined by forming the acetonide of the






To a solution of diol S14 (10.0 mg, 0.0340 mmol) in CH2Cl2/2,2-dimethoxypropane (1 mL, 1:1
v/v) was added PPTS (one crystal) and the mixture stirred for 24 h. The reaction mixture was
quenched with NaHCO3 solution (1 mL). The phases were separated and the aqueous phase
extracted with CH2Cl2 (3 × 1 mL). The combined organic extracts were dried with MgSO4,
concentrated in vacuo and purified by flash column chromatography (P.E. 40-60:EtOAc, 12:1)
to give acetonide S13 as a colourless oil (11.0 mg, 0.0320 mmol, 94%).
Rf: 0.66 (PE:EtOAc, 6:1).
1H NMR (400 MHz, CDCl3): δ 7.24 (2H, d, J = 8.6 Hz,
HPMB Ar-H ), 6.88 (2H, d, J = 8.6 Hz, HPMB Ar-H ), 5.02 (1H, m, H15A), 4.86 (1H, m, H15B),
4.46 (1H, d, J = 11.8 Hz, HPMB ArCH2O), 4.37 (1H, d, J = 11.8 Hz, HPMB ArCH2O), 4.21 (1H,
m, H17), 3.81 (3H, s, MeOPMB), 3.71 (1H, dd, J = 9.5, 2.0 Hz, H19), 3.34 (2H, m, H21), 1.84
(1H, m, H20), 1.59 (1H, qt, J = 6.8, 2.0 Hz, H18), 1.63 (3H, s, Me16), 1.43 (3H, s, Meacetonide),
1.42 (3H, s, Meacetonide), 1.05 (3H, d, J = 6.6 Hz, Me20), 0.71 (3H, d, J = 6.8 Hz, Me18).
13C
NMR (125 MHz, CDCl3): δ 159.1, 142.8, 130.6, 129.2, 113.8, 110.1, 98.9, 75.6, 75.4, 72.8, 71.2,
















Figure 2: NMR analysis of acetonide S13
2.3 C11 Stereocentre
The configuration of the alcohol at C11 from the allylation reaction was determined by formation















To a stirred solution of alcohol S15 (2.0 mg, 3.0 µmol) in CH2Cl2 (0.5 mL) was added (R)-
MTPA (2.0 mg, 8.9 µmol), DCC (6.0 mg, 30 µmol) and DMAP (one crystal). The reaction
mixture was stirred for 18 h then the solvent was removed in vacuo. The crude product was
dissolved in ether (0.5 mL) and the resulting suspension filtered. The solvent was removed in
vacuo and the residue analysed without further purification.
Rf: 0.59 (PE:EtOAc, 6:1).
1H NMR (400 MHz, CDCl3): δ 7.56 (2H, m, HPh), 7.42 (3H, m,
HPh), 7.24 (2H, d, J = 8.2 Hz, HPMB Ar-H ), 6.87 (2H, d, J = 8.2 Hz, HPMB Ar-H ), 5.72 (1H,
m, H9), 5.38 (1H, t, J = 6.1 Hz, H11), 5.10 (1H, d, J = 15.1, H8A), 5.07 (1H, d, J = 8.3 Hz,
H8B), 4.86 (1H, d, J = 9.7 Hz, H17), 4.40 (2H, ABQ, J = 11.5 Hz, HPMB ArCH2O), 3.80 (3H,
s, MeOPMB), 3.56 (3H, s, MeO), 3.54 (1H, m, H19), 3.35 (1H, m, H21A), 3.34 (1H, m, H13),
3.19 (1H, m, H21B), 2.54 (1H, m, H10A), 2.46 (1H, m, H18), 2.38 (1H, m, H10B), 1.93 (1H, m,
H20), 1.91 (1H, m, H15A), 1.79 (1H, m, H12), 1.73 (1H, m, H15B), 1.69 (1H, m, H14), 1.54 (3H,
s, Me16), 0.95 (18H, m, SiCH2CH3), 0.92 (3H, m, Me18), 0.81 (3H, d, J = 6.5 Hz, Me20), 0.80
(3H, d, J = 6.7 Hz, Me12), 0.76 (3H, d, J = 4.7 Hz, Me14), 0.64 (6H, q, J = 7.9 Hz, SiCH2CH3),
















To a stirred solution of alcohol S15 (2.0 mg, 3.0 µmol) in CH2Cl2 (0.5 mL) was added (S )-
MTPA (2.0 mg, 8.9 µmol), DCC (6.0 mg, 30 µmol) and DMAP (one crystal). The reaction
mixture was stirred for 18 h then the solvent was removed in vacuo. The crude product was
dissolved in ether (0.5 mL) and the resulting suspension filtered. The solvent was removed in
vacuo and the residue analysed without further purification.
Rf: 0.59 (PE:EtOAc, 6:1).
1H NMR (400 MHz, CDCl3): δ 7.56 (2H, m, HPh), 7.42 (3H, m,
HPh), 7.24 (2H, d, J = 8.3 Hz, HPMB Ar-H ), 6.86 (2H, d, J = 8.3 Hz, HPMB Ar-H ), 5.68 (1H,
m, H9), 5.39 (1H, t, J = 6.2 Hz, H11), 5.06 (1H, d, J = 14.4, H8A), 5.03 (1H, d, J = 7.2 Hz,
H8B), 4.88 (1H, d, J = 9.7 Hz, H17), 4.40 (2H, ABQ, J = 11.5 Hz, HPMB ArCH2O), 3.79 (3H,
s, MeOPMB), 3.51 (3H, s, MeO), 3.54 (1H, m, H19), 3.35 (1H, m, H21A), 3.37 (1H, m, H13),
3.19 (1H, m, H21B), 2.46 (1H, m, H10A), 2.46 (1H, m, H18), 2.31 (1H, m, H10B), 1.92 (1H, m,
H20), 1.91 (1H, m, H15A), 1.80 (1H, m, H12), 1.73 (1H, m, H15B), 1.72 (1H, m, H14), 1.55 (3H, s,
Me16), 0.94 (18H, m, SiCH2CH3), 0.92 (3H, m, Me18), 0.86 (3H, d, J = 7.1 Hz, Me12), 0.81 (3H,




























Figure 3: ∆δ (= δS − δR) values for MTPA esters S14 and S16
2.4 C3 and C4 Stereocentres
Initial investigations towards the macrocycle fragment were conducted with the PMB protecting
group at C1. Thus, the relevant compounds in this section contain the PMB group instead of
the DMB group used in the final synthesis
The configuration of the alcohol at C3 formed in the lithium aldol reaction was determined by















To a stirred solution of alcohol S18 (5.0 mg, 11 µmol) in CH2Cl2 (0.1 mL) was added (R)-MTPA
(13.0 mg, 57.0 µmol), DCC (12.0 mg, 57.0 µmol) and DMAP (one crystal). The reaction mixture
was stirred for 18 h then the solvent was removed in vacuo. The crude product was dissolved
in ether (0.5 mL) and the resulting suspension filtered. The solvent was removed in vacuo and
the residue analysed without further purification.
Rf: 0.52 (PE:EtOAc, 4:1).
1H NMR (400 MHz, CDCl3): δ 7.55 (2H, m, Ph), 7.42 (2H, m, Ph),
7.38 (1H, m, Ph), 7.21 (2H, d, J = 8.6 Hz, HPMB Ar-H ), 6.85 (2H, d, J = 8.6 Hz, HPMB Ar-H ),
5.78 (1H, ddd, J = 9.3, 3.3, 3.3 Hz, H3), 4.78 (1H, s, H9A), 4.70 (1H, s, H9B), 4.32 (2H, ABq,
HPMB ArCH2O), 3.80 (3H, s, MeOPMB), 3.54 (3H, s, OMe), 3.28 (1H, m, H4), 3.20 (2H, m, H1),
2.51 (1H, d, J = 14.0 Hz, H7A, 2.21 (1H, d, J = 14.0 Hz, H7B, 1.93 (2H, m, H2), 1.76 (3H, s,
Me8), 1.79 (1H, m, H24A), 1.50 (1H, m, H24B), 1.43 (3H, s, Me6), 0.78 (3H, t, J = 7.5 Hz, H25),














To a stirred solution of alcohol S18 (5.0 mg, 11 µmol) in CH2Cl2 (0.1 mL) was added (S )-MTPA
(13.0 mg, 57.0 µmol), DCC (12.0 mg, 57.0 µmol) and DMAP (one crystal). The reaction mixture
was stirred for 18 h then the solvent was removed in vacuo. The crude product was dissolved
in ether (0.5 mL) and the resulting suspension filtered. The solvent was removed in vacuo and
the residue analysed without further purification.
Rf: 0.52 (PE:EtOAc, 4:1).
1H NMR (400 MHz, CDCl3): δ 7.55 (2H, m, Ph), 7.40 (3H, m,
Ph), 7.21 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 6.85 (2H, d, J = 8.5 Hz, HPMB Ar-H ), 5.75 (1H, ddd,
J = 9.3, 3.6, 3.6 Hz, H3), 4.78 (1H, s, H9A), 4.68 (1H, s, H9B), 4.37 (2H, ABq, HPMB ArCH2O),
3.79 (3H, s, MeOPMB), 3.47 (3H, s, OMe), 3.39 (2H, m, H1), 3.27 (1H, m, H4), 2.50 (1H, d, J
= 13.9 Hz, H7A, 2.19 (1H, d, J = 13.9 Hz, H7B, 1.98 (2H, m, H2), 1.75 (3H, s, Me8), 1.67 (1H,































Figure 5: The diagnostic coupling constant in aldol adduct S5
The configuration of the adjacent ethyl group at C4 was determined by obtaining the 3JH-H
coupling constant between H3 and H4 of aldol adduct S5. At 4.8 Hz, this was within the range
observed for 1,2-syn aldol adducts and outside that observed for 1,2-anti adducts.7
2.5 C8-C9 Alkene geometry
As macrocycle 23 could not be separated from the RCM dimer byproduct, the geometry of the
C8-C9 alkene was determined by analysis of diol S8. A NOESY spectrum was recorded and the
relevant NOE releations are illustrated below. The strong positive NOE relations between H9
and H7 and between Me8 and H10 (shown in green below), along with the absence of an NOE
between Me8 and H9 and between H7 and H10 (shown in red below) confirmed the desired E











Figure 6: Selected NOE relations in diol S8
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3 NMR Comparison Tables
Table 1: NMR comparison of natural and synthetic actinoallolide A in CDCl3
Natural Synthetic
Atom 13C 1H 13C 1H
1 170.2 170.2
2 46.7 2.91 (1H, d, J = 12.0 Hz) 46.7 2.91 (1H, d, J = 12.0 Hz)
2.77 (1H, d, J = 12.0 Hz) 2.77 (1H, d, J = 12.0 Hz)
3 102.3 102.3
4 53.1 2.83 (1H, dd, J = 8.0, 5.6 Hz) 53.3 2.83 (1H, dd, J = 7.6, 5.5 Hz)
5 217.6 217.7
6 82.2 82.1
7 48.9 2.35 (1H, d, J = 13.4 Hz) 48.9 2.36 (1H, d, J = 13.4 Hz)
2.30 (1H, d, J = 13.4 Hz) 2.30 (1H, d, J = 13.4 Hz)
8 131.7 131.7
9 126.5 5.13 (1H, brdd, J = 7.8, 7.8 Hz) 126.5 5.13 (1H, dd, J = 7.8, 7.8 Hz)
10 29.9 2.49 (1H, m) 29.9 2.50 (1H, m)
2.34 (1H, m) 2.34 (1H, m)
11 73.6 5.40 (1H, ddd, J = 7.2, 7.2, 2.0 Hz) 73.6 5.40 (1H, ddd, J = 7.1, 7.1, 1.8 Hz)
12 40.5 1.78 (1H, dqd, J = 9.4, 6.8, 2.0 Hz) 40.6 1.78 (1H, m)
13 76.5 3.26 (1H, dd, J = 9.4, 2.2 Hz) 76.6 3.26 (1H, ddd, J = 9.4, 2.3, 2.3 Hz)
14 32.2 1.81 (1H, m) 32.2 1.83 (1H, m)
15 38.8 2.13 (1H, brd, J = 11.6 Hz) 38.8 2.13 (1H, d, J = 11.0 Hz)
1.79 (1H, m) 1.78 (1H, m)
16 133.7 133.7
17 128.8 4.88 (1H, brd, J = 10.0 Hz) 128.8 4.88 (1H, d, J = 9.8 Hz)
18 36.0 2.45 (1H, ddq, J = 10.0, 9.7, 6.8 Hz) 35.9 2.46 (1H, m)
19 74.9 3.64 (1H, dd, J = 9.7, 2.1 Hz) 74.9 3.64 (1H, ddd, J = 9.4, 2.3, 2.3 Hz)
20 47.5 2.67 (1H, qd, J = 6.9, 2.1 Hz) 47.5 2.67 (1H, qd, J = 7.3, 2.2 Hz)
21 217.3 217.3
22 34.8 2.50 (1H, m) 34.8 2.52 (1H, m)
2.45 (1H, m) 2.44 (1H, m)
23 7.7 1.04 (3H, t, J = 6.2 Hz) 7.7 1.05 (3H, t, J = 7.5 Hz)
24 18.4 1.84 (1H, m) 18.7 1.84 (1H, m)
1.61 (1H, m) 1.61 (1H, m)
25 12.1 1.14 (3H, t, J = 7.4 Hz) 12.1 1.14 (3H, t, J = 7.5 Hz)
26 26.8 1.34 (3H, s) 26.8 1.34 (3H, s)
27 17.2 1.47 (3H, brs) 17.2 1.47 (3H, s)
28 10.3 1.01 (3H, d, J = 6.8 Hz) 10.2 1.01 (3H, d, J = 7.0 Hz)
29 16.9 0.88 (3H, d, J = 6.4 Hz) 16.9 0.89 (3H, d, J = 6.6 Hz)
30 16.1 1.63 (3H, d, J = 1.2 Hz) 16.1 1.63 (3H, s)
31 17.9 1.05 (3H, d, J = 6.8 Hz) 17.9 1.05 (3H, d, J = 6.4 Hz)
32 9.4 1.07 (3H, d, J = 6.9 Hz) 9.4 1.07 (3H, d, J = 7.0 Hz)
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Table 2: NMR comparison of natural and synthetic actinoallolide B in CDCl3
Natural Synthetic
Atom 13C 1H 13C 1H
1 170.1 170.1
2 46.6 2.91 (1H, d, J = 12.2 Hz) 46.7 2.91 (1H, d, J = 12.1 Hz)
2.75 (1H, d, J = 12.2 Hz) 2.77 (1H, d, J = 12.1 Hz)
3 102.3 102.3
4 53.3 2.82 (1H, dd, J = 8.2, 5.8 Hz) 53.3 2.84 (1H, dd, J = 7.9, 5.8 Hz)
5 217.8 217.7
6 82.1 82.1
7 48.9 2.35 (1H, d, J = 13.6 Hz) 48.9 2.35 (1H, m)
2.28 (1H, d, J = 13.6 Hz) 2.29 (1H, m)
8 131.7 131.7
9 126.5 5.13 (1H, brdd, J = 7.4, 7.4 Hz) 126.5 5.13 (1H, dd, J = 7.5, 7.5 Hz)
10 29.8 2.52 (1H, m) 29.9 2.51 (1H, m)
2.32 (1H, m) 2.33 (1H, m)
11 73.6 5.38 (1H, ddd, J = 7.2, 7.2, 1.6 Hz) 73.6 5.39 (1H, ddd, J = 7.9, 7.9, 1.8 Hz)
12 40.6 1.78 (1H, m) 40.6 1.78 (1H, m)
13 76.6 3.26 (1H, dd, J = 9.4, 2.2 Hz) 76.6 3.26 (1H, ddd, J = 9.6, 4.9, 2.6 Hz)
14 32.4 1.80 (1H, m) 32.4 1.82 (1H, m)
15 38.7 2.12 (1H, brd, J = 11.8 Hz) 38.7 2.12 (1H, d, J = 12.4 Hz)
1.77 (1H, m) 1.77 (1H, m)
16 133.2 133.2
17 129.1 4.88 (1H, brd, J = 10.0 Hz) 129.1 4.88 (1H, d, J = 9.9 Hz)
18 36.8 2.52 (1H, m) 36.8 2.52 (1H, m)
19 82.0 3.51 (1H, dd, J = 9.6, 1.6 Hz) 82.0 3.52 (1H, d, J = 9.5 Hz)
20 37.8 1.65 (1H, m) 37.8 1.66 (1H, m)
21 79.3 3.70 (1H, ddd, J = 7.8, 7.8, 2.0 Hz) 79.3 3.71 (1H, dd, J = 7.2, 6.2 Hz)
22 28.1 1.52 (1H, m) 28.1 1.53 (1H, m)
1.42 (1H, m) 1.42 (1H, m)
23 10.4 0.90 (3H, t, J = 7.6 Hz) 10.4 0.90 (3H, t, J = 7.4 Hz)
24 18.4 1.82 (1H, m) 18.4 1.84 (1H, m)
1.59 (1H, m) 1.61 (1H, m)
25 12.1 1.13 (3H, t, J = 7.4 Hz) 12.0 1.14 (3H, t, J = 7.5 Hz)
26 26.8 1.34 (3H, s) 26.8 1.34 (3H, s)
27 17.2 1.47 (3H, d, J = 0.8 Hz) 17.2 1.47 (3H, d, J = 0.8 Hz)
28 10.3 1.00 (3H, d, J = 6.8 Hz) 10.3 1.00 (3H, d, J = 7.0 Hz)
29 17.0 0.88 (3H, d, J = 6.4 Hz) 17.0 0.88 (3H, d, J = 6.4 Hz)
30 16.2 1.62 (3H, d, J = 1.2 Hz) 16.2 1.63 (3H, d, J = 0.7 Hz)
31 17.9 1.03 (3H, d, J = 6.8 Hz) 17.9 1.04 (3H, d, J = 6.6 Hz)
32 4.2 0.84 (3H, d, J = 7.2 Hz) 4.2 0.84 (3H, d, J = 7.1 Hz)
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Table 3: NMR comparison of natural and synthetic actinoallolide C in CDCl3
Natural Synthetic
Atom 13C 1H 13C 1H
1 168.3 168.4
2 37.5 3.63 (1H, d, J = 11.4 Hz) 37.6 3.64 (1H, d, J = 11.4 Hz)





7 47.9 2.47 (1H, d, J = 13.0 Hz) 47.9 2.46 (2H, m)
2.43 (1H, d, J = 13.0 Hz)
8 131.0 131.0
9 126.2 5.16 (1H, brdd, J = 7.8, 7.8 Hz) 126.2 5.17 (1H, dd, J = 7.9, 7.9 Hz)
10 29.9 2.48 (1H, m) 29.9 2.49 (1H, m)
2.30 (1H, m) 2.31 (1H, m)
11 76.0 5.27 (1H, ddd, J = 6.8, 6.8, 1.6 Hz) 76.0 5.28 (1H, ddd, J = 6.9, 6.9, 1.7 Hz)
12 41.1 1.79 (1H, m) 41.1 1.80 (1H, m)
13 76.6 3.27 (1H, dd, J = 9.2, 2.4 Hz) 76.6 3.27 (1H, m)
14 32.2 1.82 (1H, m) 32.2 1.84 (1H, m)
15 38.9 2.13 (1H, brd, J = 12.4 Hz) 38.9 2.13 (1H, d, J = 12.6 Hz)
1.80 (1H, m) 1.80 (1H, m)
16 133.7 133.7
17 128.8 4.88 (1H, brd, J = 10.0 Hz) 128.8 4.88 (1H, d, J = 9.9 Hz)
18 35.9 2.44 (1H, m) 36.0 2.46 (1H, m)
19 74.9 3.64 (1H, dd, J = 8.8, 2.0 Hz) 74.9 3.64 (1H, m)
20 47.5 2.67 (1H, qd, J = 7.2, 2.0 Hz) 47.5 2.67 (1H, qd, J = 7.2, 2.2 Hz)
21 217.2 217.3
22 34.7 2.46 (2H, m) 34.8 2.48 (2H, m)
23 7.7 1.04 (3H, t, J = 7.2 Hz) 7.7 1.05 (3H, t, J = 7.0 Hz)
24 14.9 2.19 (2H, m) 14.9 2.23 (2H, m)
25 12.3 1.04 (3H, t, J = 7.2 Hz) 12.3 1.05 (3H, t, J = 7.0 Hz)
26 22.2 1.41 (3H, s) 22.3 1.41 (3H, s)
27 17.0 1.43 (3H, brs) 17.0 1.44 (3H, s)
28 10.3 1.00 (3H, d, J = 6.8 Hz) 10.4 1.01 (3H, d, J = 7.0 Hz)
29 17.0 0.89 (3H, d, J = 6.4 Hz) 17.0 0.89 (3H, d, J = 6.4 Hz)
30 16.1 1.63 (3H, d, J = 0.8 Hz) 16.1 1.63 (3H, s)
31 17.9 1.05 (3H, d, J = 7.2 Hz) 17.9 1.05 (3H, d, J = 7.1 Hz)
32 9.4 1.07 (3H, d, J = 7.2 Hz) 9.4 1.07 (3H, d, J = 7.2 Hz)
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Table 4: NMR comparison of natural and synthetic actinoallolide D in CDCl3
Natural Synthetic
Atom 13C 1H 13C 1H
1 168.3 168.3
2 37.5 3.63 (1H, d, J = 11.4 Hz) 37.5 3.63 (1H, d, J = 11.4 Hz)





7 47.9 2.47 (1H, d, J = 13.2 Hz) 47.9 2.47 (1H, d, J = 13.2 Hz)
2.43 (1H, d, J = 13.2 Hz) 2.43 (1H, d, J = 13.2 Hz)
8 130.9 130.9
9 126.2 5.17 (1H, brdd, J = 8.0, 8.0 Hz) 126.2 5.16 (1H, dd, J = 7.7, 7.7 Hz)
10 29.9 2.48 (1H, m) 29.9 2.49 (1H, m)
2.28 (1H, m) 2.29 (1H, m)
11 76.0 5.27 (1H, ddd, J = 6.8, 6.8, 1.6 Hz) 76.0 5.27 (1H, ddd, J = 7.0, 7.0, 1.3 Hz)
12 41.1 1.80 (1H, m) 41.1 1.79 (1H, m)
13 76.9 3.27 (1H, dd, J = 9.6, 2.4 Hz) 76.6 3.27 (1H, ddd, J = 9.0, 5.2, 2.7 Hz)
14 32.3 1.82 (1H, m) 32.3 1.82 (1H, m)
15 38.8 2.11 (1H, brd, J = 12.4 Hz) 38.7 2.12 (1H, d, J = 12.1 Hz)
1.78 (1H, m) 1.78 (1H, d, J = 12.1 Hz)
16 133.2 133.2
17 129.1 4.88 (1H, brd, J = 9.6 Hz) 129.1 4.88 (1H, d, J = 9.8 Hz)
18 36.8 2.50 (1H, m) 36.8 2.51 (1H, m)
19 82.0 3.52 (1H, dd, J = 9.2, 1.6 Hz) 82.0 3.52 (1H, d, J = 9.5 Hz)
20 37.8 1.66 (1H, m) 37.8 1.65 (1H, m)
21 79.3 3.70 (1H, ddd, J = 6.0, 6.0, 1.8 Hz) 79.3 3.71 (1H, dd, J = 6.7, 6.7 Hz)
22 28.1 1.50 (1H, m) 28.1 1.53 (1H, m)
1.40 (1H, m) 1.41 (1H, m)
23 10.4 0.90 (3H, t, J = 7.4 Hz) 10.4 0.90 (3H, t, J = 7.4 Hz)
24 14.9 2.28 (1H, m) 14.9 2.27 (1H, m)
2.19 (1H, m) 2.19 (1H, m)
25 12.3 1.05 (3H, t, J = 7.2 Hz) 12.3 1.04 (3H, t, J = 7.2 Hz)
26 22.2 1.41 (3H, s) 22.2 1.41 (3H, s)
27 17.0 1.43 (3H, brs) 17.0 1.43 (3H, s)
28 10.4 1.00 (3H, d, J = 7.2 Hz) 10.4 1.00 (3H, d, J = 7.0 Hz)
29 17.1 0.89 (3H, d, J = 6.0 Hz) 17.1 0.89 (3H, d, J = 6.5 Hz)
30 16.2 1.63 (3H, d, J = 0.8 Hz) 16.2 1.63 (3H, s)
31 17.9 1.04 (3H, d, J = 7.2 Hz) 17.9 1.04 (3H, d, J = 6.8 Hz)
32 4.2 0.84 (3H, d, J = 7.2 Hz) 4.2 0.84 (3H, d, J = 7.1 Hz)
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Table 5: NMR comparison of natural and synthetic actinoallolide E in CDCl3
Natural Synthetic
Atom 13C 1H 13C 1H
1 166.7 166.7
2 35.9 3.82 (1H, d, J = 14.8 Hz) 36.0 3.82 (1H, d, J = 14.8 Hz)





7 46.4 2.62 (1H, d, J = 13.8 Hz) 46.4 2.62 (1H, d, J = 13.6 Hz)
2.47 (1H, d, J = 13.8 Hz) 2.47 (1H, d, J = 13.6 Hz)
8 130.7 130.7
9 126.6 5.22 (1H, brdd, J = 8.0, 8.0 Hz) 126.6 5.23 (1H, dd, J = 8.2, 8.2 Hz)
10 35.2 2.23 (1H, m) 35.2 2.24 (1H, m)
1.96 (1H, m) 1.97 (1H, m)
11 72.7 3.26 (1H, dd, J = 9.2, 1.2 Hz) 72.7 3.26 (1H, d, J = 8.8 Hz)
12 40.2 1.53 (1H, m) 40.2 1.54 (1H, m)
13 81.4 4.97 (1H, dd, J = 9.4, 2.2 Hz) 81.4 4.97 (1H, dd, J = 9.4, 2.1 Hz)
14 31.6 1.91 (1H, m) 31.6 1.93 (1H, m)
15 39.4 2.12 (1H, brd, J = 14.0 Hz) 39.5 2.13 (1H, d, J = 13.2 Hz)
1.68 (1H, m) 1.68 (1H, dd, J = 13.2, 11.7 Hz)
16 132.9 132.9
17 129.4 4.81 (1H, brd, J = 10.0 Hz) 129.4 4.82 (1H, d, J = 10.0 Hz)
18 35.8 2.46 (1H, m) 35.8 2.47 (1H, m)
19 74.8 3.64 (1H, dd, J = 9.2, 2.0 Hz) 74.8 3.65 (1H, d, J = 9.2 Hz)
20 47.5 2.66 (1H, qd, J = 7.2, 2.0 Hz) 47.5 2.65 (1H, qd, J = 7.2, 2.2 Hz)
21 217.3 217.3
22 34.8 2.54 (1H, m) 34.8 2.56 (1H, m)
2.49 (1H, m) 2.48 (1H, m)
23 7.7 1.06 (3H, t, J = 7.4 Hz) 7.7 1.06 (3H, t, J = 7.3 Hz)
24 15.6 2.30 (1H, m) 15.6 2.30 (1H, m)
2.22 (1H, m) 2.22 (1H, m)
25 13.1 1.11 (3H, t, J = 7.6 Hz) 13.1 1.11 (3H, t, J = 7.5 Hz)
26 24.9 1.36 (3H, s) 24.9 1.36 (3H, s)
27 17.7 1.53 (3H, brs) 17.7 1.53 (3H, s)
28 8.1 0.94 (3H, d, J = 7.2 Hz) 8.1 0.95 (3H, d, J = 7.2 Hz)
29 16.5 0.81 (3H, d, J = 6.8 Hz) 16.5 0.81 (3H, d, J = 6.8 Hz)
30 15.9 1.62 (3H, d, J = 0.8 Hz) 15.9 1.63 (3H, s)
31 17.9 1.04 (3H, d, J = 6.8 Hz) 17.9 1.05 (3H, d, J = 6.4 Hz)
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